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ABSTRACT 
  In most metazoans, early embryogenesis is controlled by the translational 
regulation of maternally supplied mRNA. Sequence-specific RNA-binding proteins play an 
important role in regulating early embryogenesis, yet their specificities and regulatory targets 
are largely unknown. To understand how these RNA-binding proteins select their targets, my 
research focused on the C. elegans CCCH-type tandem zinc finger protein POS-1. Embryos 
lacking maternally supplied POS-1 die prior to gastrulation, and exhibit defects in the 
specification of pharyngeal, intestinal, and germline precursor cells. To identify the 
regulatory targets that contribute to the POS-1 mutant phenotype, we set out to determine the 
sequence specificity of POS-1 in vitro, and then use this information to identify regulatory 
targets in vivo.  
 Using a candidate-based search, we identified a twelve-nucleotide fragment of the 
mex-3 3' untranslated region (3' UTR) to which POS-1 binds with high affinity. Using 
quantitative fluorescent electrophoretic mobility shift assays, I determined the affinity of the 
RNA-binding domain of POS-1 for a panel of single nucleotide mutations of this sequence, 
and then defined a consensus binding element based on this dataset. POS-1 recognizes the 
degenerate element UAU2-3RDN1-3G, where R is any purine (adenosine or guanine), and D is 
any base except cytosine.  A bioinformatics analysis revealed the presence of this element in 
approximately 40% of C. elegans 3' UTRs, suggesting that POS-1 is capable of binding to 
and perhaps regulating many transcripts in vivo. POS-1 binding sites alone are not sufficient 
to pattern the expression of a reporter, suggesting that other factors may contribute to POS-1 
specificity. 
 v 
 To address the mechanism of POS-1-mediated translational regulation, I investigated 
the translational regulation of the C. elegans Notch homolog glp-1. Previous work 
demonstrated that glp-1 translation is repressed in the early embryo in a POS-1-dependent 
fashion, though it was not clear if this regulation was direct. The glp-1 3' UTR contains two 
POS-1 binding sites within five nucleotides of each other, and these sites are within a thirty-
nucleotide region of the 3' UTR required for proper spatiotemporal translation of glp-1. The 
POS-1 sites overlap with a negative regulatory element that is recognized by GLD-1, and a 
positive regulatory element recognized by an unknown factor. Both POS-1 and GLD-1 bind 
to an RNA containing these sites in vitro, and POS-1 competes with GLD-1 for binding.  
Both proteins are required for translational repression of a glp-1 3′ UTR reporter in embryos. 
Furthermore, only one of the two POS-1 binding sites is required for repression, and the 
required site is wholly contained within a previously characterized positive regulatory 
element. Based on this, we propose that POS-1 does not regulate its targets by recruiting 
regulatory machinery, but instead by competing with factors that do. Thus, sites of POS-1 
regulation are highly context dependent, which may contribute to POS-1 specificity.  
 vi 
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Chapter I 
Sequence specific RNA-binding proteins in 
C. elegans development 
 
 2 
 Prior to fertilization, oocytes remain arrested in meiosis, sometimes for a period 
of many years.  Once fertilization takes place, the oocyte becomes active and a cascade of 
rapid events occurs.  The maternal pronucleus completes meiosis and fuses with the 
paternal pronucleus, which triggers a series of cell divisions that dramatically increase the 
number of cells present in the embryo without increasing its volume.  While these 
divisions are taking place, the rough body plan of the developing organism is established.  
Body axes are specified, the germline and soma are differentiated from one another, and 
the identities of the future endoderm, mesoderm, and ectoderm are established.  What is 
remarkable about this process is that it occurs largely without the benefit of zygotic 
transcription. In sea urchins (S. purpuratus), nematodes (C. elegans), fruit flies (D. 
melanogaster), zebrafish (D. rerio), and african clawed frogs (X. laevis), zygotic 
transcription is completely inhibited for at least the first 1-2 cycles of division, and 
embryos can reach the hundred cell stage even when transcription is inhibited (reviewed 
in Tadros and Lipshitz 2009).  Transcription is reduced or inhibited in the final stages of 
mouse oocyte development (Moore and Lintern-Moore 1978), and it reinitiates at 
roughly the first embryonic division (Moore 1975). Embryogenesis occurs at a slower 
pace in mice versus other metazoans, so transcription is inhibited for twenty hours or 
more after fertilization. Thus, the earliest events in the development of most multicellular 
organisms is driven by translational regulation of maternally supplied mRNAs (reviewed 
in Farley and Ryder 2008).  
The transcription of mRNAs encoding proteins required to carry out the 
developmental programs of early embryogenesis occurs during oogenesis, but the 
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activities of these proteins are not required until after fertilization.  Thus, transcripts 
encoding such proteins must be translationally repressed within the developing oocyte, as 
well as stored for later use in the embryo.  This phenomenon is particularly noticeable in 
the specification of germ cell fates in flies, worms, frogs, and zebrafish.  During 
oogenesis, each of these species generates granular structures containing mRNAs and 
RNA-binding proteins called germ plasm. After fertilization, germ plasm localizes to a 
specific region of the embryo, and eventually segregates to only a few cells by a variety 
of mechanisms. The subset of cells that inherit germ plasm are fated to produce the entire 
germ line in the adult organism. This illustrates the role that the localization of maternally 
supplied factors plays in the specification of cell fates in the early embryo. 
 Outside of germ line specification, many maternally supplied transcripts exhbit 
localized expression patterns during embryogenesis. For example, during Drosophila 
embryogenesis, mRNAs transcribed from approximately 20% of fly genes exhibit 
restricted expression patterns.  Lecuyer and colleagues examined the localization patterns 
of approximately 3400 transcripts (about 25% of the genome) in the syncytial Drosophila 
melanogaster embryo by high resolution fluorescent in situ hybridization.  Of these, 
approximately 2300 were expressed in the embryo, and of the expressed transcripts, 71% 
(approximately 1600) exhibit a restricted localization pattern (Lécuyer et al. 2007).  The 
patterns observed can be grouped into at least thirty-five distinct localization categories, 
with slight differences between members of each category.  Extrapolating the proportion 
of localized transcripts observed in this study to the entire genome, it is expected that 
nearly 7000 transcripts have a distinct expression pattern in the embryo (Lécuyer et al. 
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2007).  Both the diversity in localization patterns observed, and the number of localized 
transcripts point to a broad network of transcript-specific localization that is active in the 
Drosophila embryo, and likely other species as well. 
 Throughout the entire process of oogenesis and early embryogenesis, specific 
mRNAs must be selected for participation in the appropriate regulatory pathways. Only a 
subset of the mRNAs actively transcribed within developing germ cells are localized to 
cytoplasmic granules or are otherwise translationally inhibited. After fertilization, the 
timing and localization of translation of maternally supplied mRNAs is precisely 
controlled, and a diverse ensemble of translational outcomes is essential. How are 
mRNAs targeted to the appropriate regulatory machinery within developing oocytes and 
early embryos?  
 mRNAs are sorted into the appropriate regulatory pathways by virtue of elements 
contained within their primary sequence.  Short motifs or structural elements that appear 
only in a subset of mRNAs are sufficient for segregating those mRNAs into different 
regulatory pathways. These elements are often, but not always, found upstream of the 
start codon and downstream of the stop codon in regions named the 5′ and 3′ untranslated 
regions (UTRs). Modular RNA-binding proteins recognize these elements through one or 
more RNA-binding domains. These proteins also typically contain one or more catalytic 
or regulatory domains. Thus, the RNA-binding protein serves to connect specific 
transcripts with the appropriate regulatory machinery (reviewed in Lunde et al. 2007).  
Two distinct strategies for recognizing specific RNA sequences have evolved.  
One strategy involves RNA-binding proteins that associate with a small RNA, such as a 
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microRNA (miRNA) or a small interfering RNA (siRNA) (reviewed in Ghildiyal and 
Zamore 2009).  These short RNAs base pair with the target sequence, and thus direct the 
RNA-binding protein to the target.  As these proteins rely on base pairing between their 
associated small RNA and the target sequence, the sequence specificities of small-RNA 
associated proteins are at least partially understood (reviewed in Pasquinelli 2012). The 
other strategy employed for recognizing specific sequence elements involves RNA-
binding proteins that make direct contact with the sequence element.  There are many 
different types of RNA-binding domains, each with a different sequence specificity 
(reviewed in Glisovic et al. 2008). As these proteins do not derive their specificity from 
an associated small RNA, it is much more challenging to predict the specificity of any 
member of this class of proteins. Thus, our understanding of the sequence specificity of 
RNA-binding domains that directly contact their target RNAs is far from complete. 
 RNA-binding proteins are common in the genomes of eukaryotes.  Bioinformatic 
predictions based on homology to previously identified RNA-binding domains estimate 
that somewhere between 2% and 3% of all proteins encoded by the genomes of D. 
melanogaster and C. elegans are capable of recognizing RNA (Lasko 2000; Lee and 
Schedl 2006).  As these estimates only consider genes with sequences that are 
homologous to known RNA-binding domains, it is possible that it is an underestimate.  A 
recent study performed by the Hentze lab identified the ensemble of proteins that interact 
with polyadenylated mRNA within HeLa cells (Castello et al. 2012). Many of the 
proteins identified have never been experimentally shown to interact with RNA, and 315 
proteins that have no RNA-related functional annotation reproducibly associate with 
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poly(A) mRNA (Castello et al. 2012). Thus, there is a large network of transcripts that are 
regulated post-transcriptionally, and a large number of potential specificity factors that 
regulate those targets.  One of the main challenges in the field of post-transcriptional 
regulation is mapping the specificity factors to their regulatory targets. This is especially 
challenging for sequence specific RNA-binding proteins, as they usually recognize a 
specificity element that is between 4 and 12 nucleotides long (Keene 2007) and is likely 
to be quite common in the transcriptome.  
 Multiple techniques have been developed to assess which sequences an RNA-
binding protein recognizes in vivo. RIP-Chip (Keene et al. 2006), CLIP (Licatalosi et al. 
2008), and PAR-CLIP (Hafner et al. 2010) all rely on specific immunoprecipitation of 
RNA-binding protein-mRNA complexes from tissues. Each of these techniques allows 
for a genome-scale identification of bound mRNAs in a model-unbiased manner. The 
antibodies can be raised against the endogenous protein, or an epitope-tagged version can 
be expressed as a transgene in the organism of interest.  RIP-Chip is typically performed 
without chemical or ultraviolet crosslinking (Keene et al. 2006), which allows RNA-
binding proteins to repartition in extract and potentially associate with mRNAs they 
never bind to in a biologically relevant context (Riley et al. 2012).  To prevent 
repartitioning, two immunprecipitation techniques that crosslink RBPs prior to tissue 
homogenization have been developed. Crosslinking and immunoprecipitation (CLIP) 
uses short wavelength UV radiation to crosslink RBPs to the mRNAs they interact with 
in vivo (Licatalosi et al. 2008). This permits the use of harsh pulldown and washing 
conditions, which allows for a significant reduction of non-specifically bound material 
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relative to RIP-Chip. However, crosslinking with short wavelength UV radiation is not 
very efficient, and CLIP suffers from low recovery efficiencies (Hafner et al. 2010).  To 
address this issue, the Tuschl lab developed a technique called Photoactivatable-
Ribonucleoside Enhanced Crosslinking and Immunoprecipitation (PAR-CLIP). This 
method incorporates a photoactivatable crosslinker (usually 4-thiouracil) into the mRNA 
of the tissue to be used in the pulldown.  This modification crosslinks efficiently using 
long wavelength UV radiation.  In addition, after the crosslinks have been reversed, a 
predictable base conversion occurs, which permits the identification of locations within 
the recovered mRNA that the RBP was interacting with directly (Hafner et al. 2010).  
Modified ribonucleosides can be introduced into living organisms, such as C. elegans, 
which allows for crosslinking from living tissue (Jungkamp et al. 2011). All three of these 
techniques produce a wealth of information regarding what an RNA-binding protein 
binds to in vivo. However, binding of an RNA-binding protein to an mRNA may not 
always result in a regulatory event, so the set of all mRNAs associated with a given RBP 
may include some mRNAs that are not regulated by that RBP.  
To study the problem of RNA-binding protein functional target specificity, a 
combination of in vitro and in vivo experimentation is essential. The gametogenesis and 
embryogenesis of the roundworm Caenorhabditis elegans provides an attractive model 
system in which to address these questions.  The vast majority of animals are self-fertile 
hermaphrodites (reviewed in Riddle et al. 1997), with a well-defined switch from 
spermatocyte to oocyte production (Riddle et al. 1997).  Gametogenesis occurs 
sequentially within the germline, allowing for all steps of gametogenesis to be observed 
 8 
within one animal (Riddle et al. 1997).  The generaton time of C. elegans is short (at 20 
ºC, an entire life cycle is complete in approximately 3 days) (Riddle et al. 1997), 
permitting for rapid proliferation of worms and rapid progress through gametogenesis 
and development.  Animals are transparent, permitting developmental events to be 
readily observed in intact animals.  The expression of genes within the animal can be 
robustly knocked down via RNA interference (RNAi), allowing for the biological 
function of genes of interest to be conveniently studied (Fire et al. 1998).  Transgenes can 
be introduced into the worm by a variety of methods (Stinchcomb et al. 1985; Mello et al. 
1991; Kelly et al. 1997; Praitis et al. 2001; Frøkjaer-Jensen et al. 2008), which provides 
an opportunity to investigate post-transcriptional regulatory events via reporters.  As 
described in more detail below, RNA-binding proteins play a central role in many of the 
events of development, ranging from the initial entry of mitotically dividing germ cell 
precursors into meiosis (reviewed in Kimble and Crittenden 2007) to cell fate 
specification events in the developing embryo (reviewed in Maduro 2010).  
  
C. elegans hermaphrodite germline physiology and embryogenesis 
 Each hermaphrodite animal contains two complete gonad arms that each begin 
with a small population of mitotically dividing germline stem cells and terminate at a 
shared uterus in the middle of the animal (Figure 1.1).  The distal end contains the 
mitotically dividing cells (Hirsh et al. 1976), while the proximal end joins with the uterus. 
 9 
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Figure 1.1. The C. elegans gonad and early embryo. Differential interference contrast 
(DIC) micrographs of the C. elegans gonad and early embryo with significant 
developmental events labeled.  Labels on embryonic cells denote the identity of the cell. 
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The gonad arm is almost as long as the worm (Hirsh et al. 1976), and it folds over on 
itself to fit within the body of the worm. As germ cells develop into gametes, they travel 
towards the proximal end of the germline (Hirsh et al. 1976). A somatic cell with 
multiple long processes that run along the basement membrane of the gonad caps each 
gonad arm (Kimble and White 1981). This cell is called the distal tip cell which expresses 
the membrane-bound Delta ligand LAG-2 (Henderson et al. 1994) that instructs the cells 
it contacts to remain in mitosis.  As germ cells migrate away from the distal tip cell, they 
transition into meiosis, migrate to the periphery of the gonad arm, and lose a portion of 
their membranes (Hirsh et al. 1976).  This generates a cylindrical syncytium (Hirsh et al. 
1976), where hundreds of nuclei all share the same cytoplasm.  It is within the syncytial 
region of the gonad that synthesis of mRNAs and proteins required for early 
embryogenesis takes place; concordant with this, transcriptional activity increases 
significantly in this region (Gibert et al. 1984).  Large ribonucleoprotein granules called 
P-granules arise in the syncytial region as well (Strome and Wood 1982; Jungkamp et al. 
2011).  These granules contain many RNA-binding proteins and mRNAs that are 
required for early embryogenesis, and are first located around the periphery of the germ 
cell nuclei (Licatalosi et al. 2008; Schisa et al. 2001; Bezares-Calderón et al. 2010).  The 
cytoplasm of the syncytial region also contains RNP granules similar to P-bodies that 
contain a different complement of mRNAs and proteins relative to P granules (Hafner et 
al. 2010; Noble et al. 2008; Jungkamp et al. 2011).  The nuclei in the syncytial  
 12 
region arrest in prophase of meiosis I, and do not progress further in meiosis until just 
prior to fertilization (Henderson et al. 1994; McCarter et al. 1999; McNally and McNally 
2005).   
 As the germ nuclei round the bend of the gonad arm and enter the proximal 
region, transcription is silenced and a small fraction of the nuclei recellularize and 
become oocytes.  The germ cell nuclei that do not become oocytes are degraded via 
apoptosis (Gumienny et al. 1999). Cytoplasmic streaming from the syncytium deposits 
factors required for embryogenesis into the developing oocytes (Wolke et al. 2007; 
Nadarajan et al. 2009). The immature oocytes approach the spermatheca, an organ that 
contains the spermatocytes generated during the final larval stage of the worm (Ward et 
al. 1981).  The spermatheca secretes a protein called Major Sperm Protein (MSP), which 
causes the resumption of meiosis (Miller et al. 2001).  As the oocyte enters the 
spermatheca, meiosis I and II are completed, and the oocyte is fertilized (Ward and Carrel 
1979). 
 Fertilization triggers a cascade of events that specify the anterior-posterior axis of 
the developing embryo.  The sperm entry point determines the posterior pole of the 
embryo by disrupting an actin-myosin network, which causes the cortex of the fertilized 
embryo to be pulled towards the anterior (Munro et al. 2004). This allows for a number 
of proteins to associate with the posterior cortex, thus polarizing the embryo along the 
anterior-posterior axis (Etemad-Moghadam et al. 1995; Boyd et al. 1996). During 
polarization, the male and female pronuclei meet in the center of the embryo, fuse and the 
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single nucleus migrates towards the posterior of the embryo along with the P granules 
(Strome and Wood 1982; 1983). The first mitotic division takes place along the anterior-
posterior axis approximately 45 minutes after fertilization, resulting in two unequally 
sized daughter cells.  The larger cell is located in the anterior, and is the first of six 
founder cells that will be generated over the course of early embryogenesis (Sulston and 
Horvitz 1977; Kimble and Hirsh 1979; Sulston et al. 1983).  Each of these cells is fated to 
produce only a limited subset of the tissue types present in the adult worm, and their fates 
are specified shortly after they are born (Sulston et al. 1983).  The anterior cell is called 
AB and will produce pharyngeal and hypodermal tissues (Figure 1.2; (Sulston et al. 
1983).  The smaller posterior cell is termed P1, and contains all of the P-granules 
deposited in the one cell embryo (Sulston et al. 1983).  This cell will divide 
asymmetrically three more times, each time producing another founder cell and a P-
lineage cell that inherits the P-granules.  The first asymmetric division of P1 generates the 
proto-founder cell EMS, the second gives rise to C, and the third produces D (Sulston et 
al. 1983). EMS divides again to make the founder cells E and MS (Sulston et al. 1983), 
which are fated to produce intestine and mesoderm, respectively (Sulston et al. 1983).  
Both C and D make muscle (Sulston et al. 1983).  The last P-lineage cell, P4 divides one 
final time during the 100-cell stage of the embryo, producing Z2 and Z3 (Sulston et al. 
1983), which populate the entire germline during larval development.  
 Many RNA-binding proteins play regulatory roles during each of the major events 
during gametogenesis and early embryogenesis.  During the switch from mitosis to 
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Figure 1.2. The cell lineage of the early C. elegans embryo.  Each founder cell is labeled 
with the tissue type it is fated to produce. 
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meiosis in the distal end of the germline, the PUF (Pumilio and FBF) proteins FBF-1 and 
FBF-2 (reviewed in Tadros and Lipshitz 2009; Crittenden et al. 2002), the Nanos 
homolog NOS-2 (reviewed in Farley and Ryder 2008; Subramaniam and Seydoux 1999) 
and the CPEB-related protein FOG-1 promote mitosis (Lécuyer et al. 2007; Barton and 
Kimble 1990), while the atypical cytoplasmic poly(A) polymerase GLD-2 in complex 
with the KH-domain containing GLD-3 (Lécuyer et al. 2007; Wang et al. 2002), and the 
STAR-domain protein GLD-1 promote meiosis (Keene 2007; Francis et al. 1995a) 
(Figure 1.3).  In addition to GLD-1, oogenesis requires the CPEB homolog CPB-3 and its 
interacting partner DAZ-1 (Licatalosi et al. 2008; Hasegawa et al. 2006; Hafner et al. 
2010; Jungkamp et al. 2011), the PUF proteins PUF-5, PUF-6, and PUF-7 (Licatalosi et 
al. 2008; Lublin and Evans 2007), and the KH-domain containing protein MEX-3 (Hafner 
et al. 2010; Pagano et al. 2009; Jungkamp et al. 2011).  Apoptosis of germ cell nuclei is 
regulated by the RNA-binding proteins CAR-1, CGH-1 and GLA-3 (Henderson et al. 
1994; Boag et al. 2005), and oocyte maturation requires the CCCH-type tandem zinc 
finger proteins OMA-1 and OMA-2 (Detwiler et al. 2001; Shimada et al. 2006).  
 Once fertilization occurs, a cascade of RNA-binding protein localization and 
translation occurs. The CCCH-type tandem zinc finger proteins MEX-5 and MEX-6 
(Schubert et al. 2000), as well as the RNA Recognition Motif (RRM) containing protein 
SPN-4 (Gomes et al. 2001) and the KH-domain containing protein MEX-3 promote 
anterior fates in the early embryo (Draper et al. 1996), while the CCCH-type tandem zinc 
finger proteins POS-1 and PIE-1 (Mello et al. 1996; Tabara et al. 1999), and the STAR-
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Figure 1.3. RNA-binding proteins involved in C. elegans gametogenesis and 
embryogenesis.  The RNA-binding proteins that participate in the listed developmental 
events are located in the approximate region of the gonad or embryo in which they are 
expressed. 
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domain containing protein GLD-1  promote posterior fates (Jones et al. 1996) (Figure 
1.3). Very little is known about the suite of targets that each of these proteins interacts 
with, and the mechanism of target regulation remains largely unknown for most of the 
RNA-binding proteins required for C. elegans development. 
 In general, these RNA-binding proteins are thought to regulate their specific 
regulatory targets through binding to specific regulatory sequences within their 3′ UTRs.  
Indeed, post-transcriptional regulation is the primary method of gene regulation within 
the germline and early embryo.  In a study performed by the Seydoux lab, the expression 
patterns of fluorescent transgenic reporters bearing a gene's promoter and a 3′ UTR that 
does not confer patterned regulation were compared with the expression patterns of 
reporters that have a pan-germline promoter and that gene's specific 3′ UTR (Merritt et 
al. 2008). For all genes tested whose encoded proteins are expressed in the germline, in 
oocytes, or in the early embryo, the 3′ UTR reporter construct mostly recapitulated the 
endogenous protein's expression pattern. On the other hand, reporters driven by the gene's 
promoter typically exhibited unpatterned expression throughout the germline and 
embryo, indicating that post-transcriptional regulation through the 3′ UTR drives gene 
expression during oogenesis and embryogenesis. The 3′ UTR reporters for sperm-
expressed genes did not faithfully recreate the corresponding endogenous protein's 
expression pattern, suggesting that gene expression in spermatocytes is regulated by 
alternative mechanisms (Merritt et al. 2008). While a general model has been proposed 
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for how RNA-binding proteins recognize their specific targets, the details for most 
individual proteins are still unknown.  
 Given the large number of RNA-binding proteins expressed in the germline, as 
well as their distinct expression patterns, it is likely that an mRNA transcribed in the 
syncytial region destined for embryonic translation is part of a dynamic mRNP complex 
whose composition changes as a function of position within the germline.  To understand 
the complete makeup of such an mRNP complex would require a detailed understanding 
of each of the RNA-binding proteins involved, their specific binding sites within the 
mRNA, and any co-factors required to elicit regulatory responses.  Our knowledge of 
RNA-binding protein mediated regulation is not yet sufficient to understand the complete 
makeup and dynamics of such an mRNP complex, but a comprehensive picture is 
beginning to emerge for a handful of regulatory targets in the C. elegans germline.  One 
such target is the Notch homolog glp-1, which is required for multiple signaling events in 
the germline and early embryo.   
 
Function and regulation of glp-1 
 GLP-1 is a member of the Notch family of transmembrane receptors, which are 
type I transmembrane proteins.  The extracellular portion of the protein contains multiple 
epidermal growth factor (EGF) motifs, followed by three repetitions of the LIN-12/Notch 
repeat sequence (Yochem and Greenwald 1989). A membrane-spanning spacer sequence 
that contains two conserved cysteines lies immiediately after the LNR sequences.  When 
GLP-1 associates with one of its ligands, this spacer sequence is cleaved at the conserved 
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cysteines, which liberates the intracellular domain of GLP-1 (Crittenden et al. 1994).  
This domain contains repeated CDC-10/Ankyrin motifs, as well as a PEST-
destabilization domain (Yochem and Greenwald 1989).  After cleavage, the intracellular 
domain of GLP-1 enters the nucleus and associates with LAG-1.  The GLP-1/LAG-1 
complex is a transcriptional activator (Neves et al. 2007) that promotes expression of 
genes downstream of the GLP-1 receptor.  
 GLP-1 protein is required for two classes of inductive events during 
gametogenesis and embryogenesis.  It is expressed on the surface of mitotically dividing 
cells in the distal arm of the gonad (Crittenden et al. 1994), where it receives a signal 
from the processes of the distal tip cell (Kimble and White 1981).  This signal is the 
membrane-associated ligand LAG-2 (Henderson et al. 1994), which instructs GLP-1 
expressing cells to remain in mitosis, and thus controls proliferation of germline 
precursor cells.  The other class of inductive events takes place in the early embryo.  glp-
1 mRNA is maternally supplied, and GLP-1 is initially expressed in two cell embryos on 
the surface of the anterior blastomere, AB (Evans et al. 1994).  After division of AB, 
GLP-1 continues to be expressed on the surface of both daughter cells, ABa and ABp 
(Evans et al. 1994).  The embryonic ligand for GLP-1 is APX-1, which is expressed on 
the surface of P2. As P2 only makes contact with ABp, GLP-1 signaling polarizes the 
descendants of AB (Mello et al. 1994; Mango et al. 1994; Evans et al. 1994).  In ABp, 
this inductive signaling mechanism causes the expression of the ref-1 family of 
transcription factors, which prevents pharyngeal fate specfication and promotes 
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hypodermal fates (Neves et al. 2007).  GLP-1 participates in three more inductive 
signaling events in the embryo which contribute to pharyngeal development, left-right 
body axis specification, and excretory cell fate specification (Priess 2005).   
 glp-1 is essential for both of these processes.  Loss of function mutations of glp-1 
were identified in two separate genetic screens; one screened specifically for sterile 
phenotypes, while the other screened for maternal effect embryonic lethal mutations.  
Hermaphrodite worms that have no zygotic glp-1 contribution are sterile, and produce 
gonad arms that contain approximately 10 germ cells (Austin and Kimble 1987), 
indicating that glp-1 is required for mitotic proliferation within the germ line.  Embryos 
lacking maternally supplied glp-1 fail to produce pharyngeal tissue, and die during 
embryogenesis (Priess et al. 1987).  A dominant gain-of-function mutation (oz112) of 
glp-1 was identified in a subsequent screen (Berry et al. 1997).  This mutation causes 
constitutively activated GLP-1 signaling, and consequently produces a tumorous germ 
line full of cells that do not exit from mitosis (Berry et al. 1997).  Thus, GLP-1 signaling 
is both necessary and sufficient for mitotic proliferation of the germline, and tight 
regulation of GLP-1 activity is essential for viable gametogenesis.  
 GLP-1 protein is expressed at the distal end of the gonad, as well as the anterior 
of the four-cell stage embryo, but glp-1 mRNA is expressed throughout the entire germ 
line as well as all cells of the early embryo (Evans et al. 1994) (Figure 1.4).  Thus, glp-1 
mRNA is translationally repressed in four distinct developmental environments: the 
syncytial region of  the gonad, recelluarizing oocytes, mature oocytes, and the early 
embryo.  Translational repression is mediated through the 369 nucleotide long 3′ UTR, as 
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Figure 1.4. Translational repression of glp-1.  The expression pattern of glp-1 mRNA is 
highlighted in tan, while the expression of GLP-1 protein is shown in green.  RNA-
binding proteins involved in regulating glp-1 are labeled in the approximate regions in 
which they participate.  
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demonstrated through the use of in vitro transcribed capped, polyadenylated reporter 
mRNAs encoding E. coli beta-galactosidase (Evans et al. 1994).  When a version of this 
mRNA that does not contain the glp-1 3′ UTR is injected into the syncytial region of 
adult hermaphrodites, beta-galactosidase expression is observed throughout the syncytial 
region, in oocytes, and in all cells of embryos (Evans et al. 1994).  When this reporter is 
fused to the glp-1 3′ UTR and similarly injected, beta-galactosidase expression is 
restricted to the anterior cells of embryos, which recapitulates the expression pattern of 
endogenous GLP-1 protein (Evans et al. 1994).  Thus, the glp-1 3′ UTR is sufficient for 
translational repression in the hermaphrodite germ line.   
 The glp-1 3′ UTR contains two regulatory elements that confer spatio-temporal 
control of glp-1 translation: the Temporal Control Region (TCR) and the Spatial Control 
Region (SCR; Figure 1.5). Removal of the TCR in the context of an injected mRNA 
reporter results in reporter expression throughout the embryo, but otherwise normal 
expression in the germ line, while removal of the SCR results in both ectopic embryonic 
expression and expression throughout the germline (Evans et al. 1994).  A 34-nucleotide 
portion of the SCR is sufficient to confer patterned regulation on an unpatterned 3′ UTR, 
suggesting that a subset of the SCR is sufficient to give rise to the appropriate pattern of 
translation of glp-1 (Marin and Evans 2003). This fragment of the SCR can be further 
subdivided into two regulatory sub-elements: the Glp-1 Repression Element (GRE) and 
the Glp-1 De-repression Element (GDE) (Marin and Evans 2003).  Mutations within the 
GRE result in expression of a reporter throughout the gonad and all cells of the early 
embryo, while mutations within the GDE result in no reporter expression at all within the
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Figure 1.5. Regulatory elements in the glp-1 3′ UTR.  Top, schematic of regulatory 
elements identified in Evans, et al 1994 and Marin and Evans, 2003. Bottom, fine 
mutagenesis performed in the context of a reporter reveals two subelements within the 
SCR. The mutations listed result in the reporter expression pattern described to the right.
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germline or embryo (Marin and Evans 2003).  The GDE mutations do not appreciably 
reduce the level of reporter mRNA present in the germline or embryo, suggesting that the 
GDE is required solely for activation of translation (Marin and Evans 2003). 
 Seven different sequence-specific RNA-binding proteins contribute to the 
expression pattern of endogenous GLP-1 in the germline and embryo (Figure 1.4).  Once 
the mitotically dividing germ cell precursors enter meiosis, translation of glp-1 is 
repressed by GLD-1, which continues to repress translation throughout the syncytial 
region of the gonad (Francis et al. 1995b; 1995a; Marin and Evans 2003). Null mutants of 
gld-1 exhibit a germline tumor similar to the glp-1 gain-of-function mutation, supporting 
the hypothesis that GLD-1 is a translational repressor of glp-1 (Francis et al. 1995a).  
Furthermore, the GRE contains a GLD-1 binding site, suggesting that this translational 
repression is direct.  As the germ nuclei destined to become oocytes begin to 
recellularize, the expression level of GLD-1 is reduced (Jones et al. 1996), and the PUF 
proteins PUF-5, PUF-6, and PUF-7 are responsible for translationally repressing glp-1 
(Lublin and Evans 2007).  Knockdown of all three genes simultaneously results in 
expression of GLP-1 in oocytes, and these oocytes fail to mature (Lublin and Evans 
2007).  PUF-5, PUF-6, and PUF-7 are no longer expressed in maturing oocytes, and it is 
thought that MEX-3 represses translation of glp-1 in maturing oocytes (Pagano et al. 
2009).  Knockdown of mex-3 in a strain harboring a fluorescent reporter bearing the glp-1 
3′ UTR results in ectopic reporter expression in all cells of the early embryo (Pagano et al. 
2009), suggesting that MEX-3 is required for glp-1 translational repression. 
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 After fertilization, five proteins are required to regulate the translation of glp-1 
mRNA.  MEX-5, MEX-6, and SPN-4 are all expressed in the anterior of the one-cell 
embryo (Schubert et al. 2000; Gomes et al. 2001; Ogura et al. 2003).  Knockdown of 
MEX-5 and MEX-6 results in no apparent expression of GLP-1 protein (Schubert et al. 
2000), while mutations in SPN-4 result in a similar expression pattern (Ogura et al. 2003).  
POS-1 and GLD-1 are required to translationally repress glp-1 in the posterior of the 
embryo; POS-1 is expressed in the posterior of the one-cell embryo shortly after 
fertilization (Tabara et al. 1999), while GLD-1 is expressed in the posterior starting from 
the four-cell stage (Jones et al. 1996).  Knockdown of either POS-1 or GLD-1 results in 
expression of GLP-1 throughout the embryo (Ogura et al. 2003; Marin and Evans 2003).  
Thus, the regulation of glp-1 translation requires a carefully coordinated suite of RNA-
binding proteins that each contribute to the translation of glp-1 at precise developmental 
phases of C. elegans oogenesis and embryogenesis.  The composition of the glp-1 mRNP 
is likely to be dynamic as it makes its way through the gonad and embryo, as RNA-
binding proteins and perhaps other regulatory factors required to translationally repress or 
activate glp-1 mRNA have limited domains of expression throughout the gonad.  No 
single group of factors has yet been identified that translationally represses glp-1 mRNA 
throughout the entire process of oogenesis and embryogenesis, and given the factors 
already identified which play a role in the regulation of glp-1, this is not likely to be the 
case.  
 To investigate the translational regulation of glp-1, or any other transcript, 
throughout development, a detailed understanding of which factors are binding to which 
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regions of the mRNA during which stages of development is required.  For glp-1, we 
have a limited amount of insight as to the binding sites for each of the factors known to 
participate in translational regulation.  The specificity of GLD-1 has been determined 
(Ryder et al. 2004), and a GLD-1 binding site is located within the GRE (Marin and 
Evans 2003). Mutations that overlap with the GLD-1 binding site result in increased 
reporter translation (Marin and Evans 2003).  Thus, it is likely that GLD-1 directly 
regulates glp-1 translation through this site.  By yeast three-hybrid assay, POS-1 and 
SPN-4 have been shown to associate with the SCR and TCR of the glp-1 3′ UTR, 
respectively (Ogura et al. 2003).  This narrows down the potential region that each protein 
recognizes to approximately 100 nucleotides, but it provides no information about the 
specific binding sites either protein recognize, the affinities of either protein for the glp-1 
3′ UTR, or the sequence specificities of either protein.  There are two matches to the 
MEX-3 consensus sequence in the glp-1 3′ UTR (Pagano et al. 2009). One is located 
within the SCR, and the other lies upstream in a region of the 3′ UTR that is dispensable 
for patterned regulation (Marin and Evans 2003; Pagano et al. 2009).  The ability of 
MEX-3 to bind to either of these sites has not been determined, nor is it known if either 
plays a role in vivo.  There is no information regarding PUF-5, PUF-6 or PUF-7 directly 
binding to the glp-1 3′ UTR, so it is not known if regulation by these factors is direct.  
Thus, our understanding of how glp-1 is regulated through time is incomplete, as is our 
understanding of most mRNAs throughout the germline.  With a better understanding of 
how sequence-specific RNA binding proteins select their targets, we could begin to map 
the mRNPs that are required for translational regulation throughout the germline. 
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Sequence specific RNA-binding proteins in C. elegans development 
 As discussed previously, many proteins containing RNA-binding domains are 
required to perform a variety of regulatory roles in oogenesis and embryogenesis.  
However, the sequence specificities of only a few are known, and the complete set of 
regulatory targets for any RBP is still unknown.  To highlight the diversity of RNA-
binding protein mediated translational regulation in C. elegans, I will discuss the RNA-
binding proteins FBF, GLD-1, MEX-3, and POS-1 as examples. 
 
FBF 
FBF (fem-3 binding factor) is the collective term for two nearly identical proteins 
encoded by fbf-1 and fbf-2.  FBF is required to make the switch from spermatocyte 
production to oocyte production in larval worms (Zhang et al. 1997; Kraemer et al. 1999), 
and it is also necessary to maintain a population of mitotically dividing germ cell 
precursors in the distal arm of the gonad (Crittenden et al. 2002).  Single mutations of 
either gene result in germ line development that is essentially wild-type, while double 
mutations result in an adult germline filled with spermatocytes and lacking a pool of 
mitotic cells (Zhang et al. 1997).  At least three regulatory targets of FBF have been 
identified: fem-3, which encodes a novel protein that promotes spermatogenesis and 
represses oogenesis (Zhang et al. 1997), gld-1, which encodes a RNA-binding protein that 
inhibits mitosis (Crittenden et al. 2002), and gld-3, which encodes a specificity factor for 
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the cytoplasmic poly(A) polymerase GLD-2 (Eckmann et al. 2004).  Together, GLD-2 
and GLD-3 are positive regulators of transcripts that promote meiosis, such as gld-1 (Suh 
et al. 2006).  FBF has been shown to directly associate with each of these transcripts both 
in vitro and in vivo, and a single nucleotide mutation that disrupts the FBF binding site in 
the fem-3 3′ UTR results in a germline that produces exclusively spermatocytes 
(Crittenden et al. 2002), supporting the hypothesis that FBF generally acts as a direct 
repressor of translation.  
   FBF is a founding member of the PUF (Pumilio and FBF) family of RNA-
binding proteins.  PUF proteins are typified by an RNA-binding domain that contains 
eight repeats of a motif comprised of three alpha helices (Zamore et al. 1997; 1999; 
reviewed in Wickens et al. 2002).  These repeats are packed together in a curved structure 
with each repeat having a similar orientation.  This generates an RNA-binding surface on 
the concave face of the RNA-binding domain.  Most PUF proteins recognize an eight 
nucleotide sequence that begins with the trinucleotide UGU and ends with the 
dinucleotide UA.  In canonical PUF domains, each one of the PUF repeats makes direct 
contact with one of the eight bases in the recognition element (Wang et al. 2001).  
However, the optimal binding sequence for FBF contains nine nucleotides 
(UGURNNAUA, where R is a purine and N is any base) (Opperman et al. 2005; 
Bernstein et al. 2005).  A series of crystal structures of the PUF domain of FBF in 
association with a variety of target sequences reveals the structural basis of flexible RNA 
recognition by FBF (Wang et al. 2009).  Each of the bases contained within the UGU and 
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AUA trinucleotides is involved in stacking interactions with amino acids of FBF, and the 
permitted identities of these nucleotides are thus significantly restricted. Bases at 
positions 4, 5, and 6, on the other hand, do not form stacking interactions with amino 
acids of the RNA-binding domain, permitting their identities to be more flexible.  The 
bases at positions 5 and 6 are flipped away from the RNA-binding domain and stacked 
directly with base 4, which allows FBF to accommodate an additional nucleotide relative 
to other PUF proteins (Wang et al. 2009; Koh et al. 2011). Depending on the identities of 
the bases at positions 4 through 6, these bases can adopt a variety of conformations.  
Thus, flexibility within an RNA recognized by an RNA-binding protein can allow that 
RNA-binding protein to recognize a variety of sequences. 
 As a result of FBF's degenerate specificity in vitro, it is capable of associating 
with many transcripts in vivo.  A genome-wide analysis of FBF-associated transcripts 
identified 1350 transcripts that are reproducibly immunoprecipitated with FBF from 
adult, hermaphrodite C. elegans extracts (Kershner and Kimble 2010).  67% of these 
transcripts contain at least one consensus FBE, compared with approximately 30% of all 
transcripts in C. elegans, demonstrating that this strategy enriches for FBF-associated 
transcripts (Kershner and Kimble 2010). However, even among the most enriched 
transcripts, only 85% contained FBEs, suggesting that FBF may be capable of 
recognizing sequences outside of its defined consensus.   
 FBF is proposed to have two distinct methods of regulating the transcripts with 
which it associates: recruitment of the CCF-1/Pop2p deadenylase, and recruitment of the 
atypical cytoplasmic poly(A) polymerase GLD-2.  FBF is a negative regulator of gld-1 
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translation in the germline of adult hermaphrodites, and translational repression is 
achieved through a high-affinity FBF binding site within the gld-1 3′ UTR.  Using an in 
vitro system based on the gld-1 3′ UTR bearing a short poly(A) tail, Suh and colleagues 
demonstrated that deadenylation can take place in the presence of purified recombinant 
FBF and CCF-1, and that this activity is dependent on the presence of a high affinity FBF 
binding site (Suh et al. 2009).  FBF associates directly with CCF-1 by yeast two-hybrid 
assay, suggesting that FBF directly recruits CCF-1 to 3′ UTRs to which it binds, and thus 
represses translation by shortening the poly(A) tail (Suh et al. 2009).  Outside of the 
germline, FBF is capable of activating translation in neurons by recruiting GLD-2. One 
target of FBF is egl-4, which encodes a kinase required to mediate odor adaptation in C. 
elegans.  The egl-4 3′ UTR contains an FBF binding site, and mutants that disrupt this 
binding site have decreased levels of EGL-4 protein expression, but no change in the 
expression level of egl-4 mRNA (Kaye et al. 2009).  These mutants also fail to adapt to 
noxious odors.  Decreased EGL-4 expression is also observed in a gld-2 mutant, 
suggesting that cytoplasmic polyadenylation is required for EGL-4 translation (Kaye et 
al. 2009).  Given that FBF associates directly with GLD-2 by yeast two-hybrid assay (Suh 
et al. 2009), it is possible that FBF is directly recruiting GLD-2 to the egl-4 3′ UTR and 
thus stimulating its translation by extending its poly(A) tail.  The basis of the apparently 
opposite regulatory activities of FBF is not well understood, but it is likely to depend on 
the cytoplasmic content of the cell where regulation is taking place, the sequence context 
of the FBF binding site, or some combination of both.  
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GLD-1 
 GLD-1 is essential for oogenesis, hermaphrodite spermatogenesis and 
embryogenesis.  The germline progenitor cells of gld-1(null) mutant worms enter meiosis 
but exit at the pachytene stage and return to mitosis; thus, the gonad is transformed into a 
mitotically dividing germline tumor and no viable oocytes or embryos are generated 
(Francis et al. 1995a).  Less severe mutant alleles of gld-1 result in defects in 
spermatogenesis and oogenesis without the formation of a germline tumor (Francis et al. 
1995b).  Adult hermaphrodite worms treated with gld-1(RNAi) produce a limited number 
of fertilized embryos prior to germline tumor formation, and these embryos arrest prior to 
gastrulation (Marin and Evans 2003).  GLD-1 is expressed in the syncytial region of the 
gonad, as well as the posterior of embryos beginning at the four-cell stage (Jones et al. 
1996).  GLD-1 has been shown to repress translation of numerous mRNAs including glp-
1, tra-2, and rme-2 (Marin and Evans 2003; Lee and Schedl 2001).  glp-1 encodes a Notch 
receptor required for mitosis as well as inductive signaling events in the early embryo.  
Tra-2 encodes a membrane protein of unknown function that is required to initiate the 
switch to oogenesis in late larval worms (Doniach 1986; Kuwabara et al. 1992), while 
rme-2 encodes a yolk receptor that is translated in recellularizing oocytes and is required 
for yolk uptake (Grant and Hirsh 1999).  GLD-1 is thus capable of repressing the 
translation of factors required for germline development events that occur both prior to 
and after the expression of GLD-1. 
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 Within the syncytial region of the germline, as well as in the posterior cells of 
early embryos, GLD-1 localizes to cytoplasmic granules. General cytoplasmic staining of 
GLD-1 is also observed in both cases (Jones et al. 1996; Noble et al. 2008).  In both 
embryos and the germline, these granules are distinct from P-granules, as GLD-1 
immunofluorescence does not colocalize with that of the P-granule component PGL-1 
(Noble et al. 2008).  Extensive analysis of the composition of the embryonic granules has 
not been performed, but the germline granules contain the RNA-binding proteins CGH-1 
and CAR-1, and do not contain the 5′ decapping enzyme DCAP-2 (Noble et al. 2008).  
CAR-1 and CGH-1, but not PGL-1, also immunoprecipitate with GLD-1 from worm 
extracts, further supporting GLD-1 being a component of these granules (Noble et al. 
2008).  Given the absence of machinery required for turnover of mRNAs, these germline 
granules may be required for the storage of translationally inactive mRNA destined for 
use in developing oocytes or post-fertilization.  Consistent with this hypothesis, 
cytoplasmic germline granules also contain mRNAs for genes required later in oogenesis 
or embryogenesis such as rme-2, pos-1, and glp-1 (Noble et al. 2008; Scheckel et al. 
2012).  An injected in vitro transcribed reporter containing the glp-1 3′ UTR localizes to 
these granules.  Reporter constructs lacking the glp-1 SCR fail to localize in the syncytial 
region and are translated, suggesting that the SCR mediates repression in the distal arm of 
the gonad, and also that granular localization is necessary for translational repression of 
glp-1 (Noble et al. 2008).  
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 GLD-1 contains a STAR RNA-binding domain.  STAR domains comprise a 
maxi-KH domain flanked by two conserved domains termed Qua1 and Qua2 (Ryder et 
al. 2004).  GLD-1 is an obligate dimer, and dimerization is mediated through the Qua1 
domain (Ryder et al. 2004).  Truncations of the protein that lack this domain not only fail 
to dimerize, but also bind RNA with a ten fold weaker affinity, indicating that 
dimerization is essential for high-affinity RNA-binding (Ryder et al. 2004).  A recent 
crystal structure of the GLD-1 Qua1 domain shows that each protomer of the dimer is 
oriented perpendicularly, which would suggest that the two RNA-binding surfaces of the 
GLD-1 dimer are distant from one another, and a substantial amount of RNA looping is 
required for binding (Beuck et al. 2010).  Consistent with this model, GLD-1 has a 
footprint of approximately 20 nucleotides on a high affinity fragment of the tra-2 3′ UTR 
(Ryder et al. 2004). GLD-1 also requires two distinct elements for the highest affinity 
binding: a core hexameric sequence of UACU(A/C)A, and an upstream UA dinucleotide 
(Ryder et al. 2004). Thus, when bound to RNA, GLD-1 is likely to occupy much more 
sequence than just its consensus binding site. 
 In addition to the storage granules described above, GLD-1 also associates with 
the F-box containing protein FOG-2 (Clifford et al. 2000).  F-box domains typically 
recruit ubiquitination machinery, which usually results in targeting of the ubiquitinylated 
protein for degradation by the proteasome.  The association between GLD-1 and FOG-2 
is required for spermatogenesis, and as each protein is essential, it is unlikely that GLD-1 
is being degraded as a result of FOG-2 association (Clifford et al. 2000).  The FOG-
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2/GLD-1 complex may target other proteins required for translation that are associated 
with the same transcript, and thus repress translation by targeting translational machinery 
for degradation (Clifford et al. 2000).  Because GLD-1 dimerizes (Ryder et al. 2004) and 
recruits multi-subunit regulatory complexes (Clifford et al. 2000), GLD-1 likely has a 
large footprint on the RNAs with which it associates. 
 
MEX-3 
 MEX-3 contains a dual-KH domain, and is expressed at both the distal end of the 
germline as well as the anterior of early embryos (Draper et al. 1996).  In the absence of 
MEX-3, AB (the anterior blastomere of the two cell embryo) produces muscle instead of 
hypodermal and pharyngeal tissues (Draper et al. 1996). This defect is thought to be the 
result of mis-regulation of the transcription factor PAL-1, which specifies muscle and 
whose activity is normally restricted to the posterior C and D blastomeres (Draper et al. 
1996). In embryos lacking MEX-3, PAL-1 is expressed in the anterior of the embryo, 
which suggests that MEX-3 plays a role in translationally repressing pal-1 in the anterior 
(Draper et al. 1996).  MEX-3 also translationally represses the nanos homolog NOS-2 in 
embryos (Subramaniam and Seydoux 1999), which may indicate that MEX-3 regulates 
many transcripts.  
Single mutations of mex-3 do not result in any apparent germline defects, but two 
double mutations have been discovered that result in substantially transformed germlines.  
Mutation of mex-3 simultaneously with puf-8, a PUF family RNA-binding protein, results 
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in a ten-fold reduction of the number of cells within the germline (Ariz et al. 2009). 
Mutation of either gene alone results in only a two-fold decrease in the number of 
mitotically proliferating cells, demonstrating redundant control of mitosis by these 
proteins (Ariz et al. 2009). If glp-1 is also mutated at the same time, these cells can exit 
mitosis and differentiate into both spermatocytes and oocytes, suggesting that MEX-3 
and PUF-8 redundantly promote mitotic proliferation only (Ariz et al. 2009).  A double 
mutation of mex-3 and gld-1 results in a germline containing cells that have 
transdifferentiated into a variety of somatic types, including neurons and muscle (Ciosk 
et al. 2006).  Thus, it is possible that MEX-3 regulates multiple transcripts required for 
preserving germ-cell fate in concert with other RNA-binding proteins.  
The specificity of the MEX-3 RNA-binding domain has been determined, and it 
recognizes the highly degenerate sequence DKAGN0-8UHUA, where D is A, G, or U, K 
is G or U, N is any base, and H is A, C, or U (Pagano et al. 2009).  This binding site is 
present in the 3′ UTRs of approximately 30% of C. elegans genes, including the known 
regulatory targets pal-1 and nos-2 (Pagano et al. 2009).  Given the high number of 
candidate MEX-3 binding sites, as well as the apparently redundant nature of MEX-3 
regulation in the germline, MEX-3 may require other, unknown factors for specific 
regulation of its targets.  In addition, the mechanism of MEX-3 mediated translational 
repression is also unknown.  
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POS-1 
POS-1 is one of 17 CCCH-type tandem zinc finger RNA-binding proteins (Tabara 
et al. 1999), in C. elegans (reviewed in Kaymak et al. 2010).  POS-1 is expressed in the 
posterior of embryos starting after fertilization, and is restricted to the posterior 
blastomeres until the four cell stage. After this point, POS-1 expression is only detectable 
in the P-lineage, where it remains until at least the hundred-cell stage.  Throughout early 
embryogenesis, POS-1 expression is predominantly cytoplasmic (Tabara et al. 1999). 
Embryos lacking POS-1 arrest prior to gastrulation with defects in three tissue types: AB-
derived pharynx, E-derived intestine, and P-lineage-derived germ cell precursors (Tabara 
et al. 1999).  The first divisions of the P-lineage are also abnormal.  In wild-type 
embryos, the pace of division of the P-lineage is slow relative to the other blastomeres, 
but in POS-1 mutant embryos, the P-lineage cell divides at a similar rate to the somatic 
blastomeres (Tabara et al. 1999).  The pleiotropic nature of the pos-1 mutant phenotype 
suggests it regulates multiple critical targets during embryogenesis.  To understand the 
biological role that POS-1-mediated translational regulation plays in the early embryo, 
we set out to determine its in vitro specificity, and then use that information to predict 
and identify critical regulatory targets.  Chapter II describes the in vitro biochemical 
characterization of the RNA-binding domain of POS-1, including a comprehensive 
determination of its sequence specificity.  Chapter III describes the POS-1-mediated 
regulation of glp-1 in concert with the RNA-binding protein GLD-1. 
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Chapter II 
RNA target specificity of embryonic cell 
fate determinant POS-1 
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ABSTRACT  
Specification of Caenorhabditis elegans body axes and cell fates occurs prior to 
the activation of zygotic transcription.  Several CCCH-type tandem zinc finger (TZF) 
proteins coordinate local activation of quiescent maternal mRNAs after fertilization, 
leading to asymmetric expression of factors required for patterning.  The primary 
determinant of posterior fate is the TZF protein POS-1.  Mutants of pos-1 are maternal 
effect lethal with a terminal phenotype that includes excess pharyngeal tissue and no 
endoderm or germline.  Here, we delineate the consensus POS-1 recognition element 
(PRE) required for specific recognition of its target mRNAs.  The PRE is necessary but 
not sufficient to pattern the expression of a reporter.  The PRE is distinct from sequences 
recognized by related proteins from both mammals and nematodes, demonstrating that 
variants of this protein family can recognize divergent RNA sequences.  The PRE is 
found within the 3′ untranslated region of 227 maternal transcripts required for early 
development, including genes involved in endoderm and germline specification.  The 
results enable prediction of novel targets that explain the pleiotropy of the pos-1 
phenotype. 
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INTRODUCTION 
 During the first few rounds of cell division in the development of a metazoan, 
body axes are formed, cell fates are specified, and a rough body plan is established.  In 
many species, these events occur without the benefit of zygotic transcription, relying 
instead on the asymmetric localization and translation of specific maternally-supplied 
mRNAs (reviewed in Farley and Ryder 2008).  A network of cis-acting regulatory 
elements and cognate trans-acting specificity factors, including RNA-binding proteins 
and microRNAs, is required to ensure that mRNAs are appropriately regulated.  
Frequently, the cis-acting regulatory elements are found in the 3′ untranslated region (3′ 
UTR) of mRNAs, as this region is not actively translated and is therefore readily 
accessible to the trans-acting regulatory factors (reviewed in Kuersten and Goodwin 
2003).  
 Early embryogenesis in the nematode Caenorhabditis elegans requires the 
regulation of an extensive network of maternally supplied mRNAs, as the onset of 
zygotic transcription is delayed.  Prior to the initiation of zygotic transcription, the fates 
of all of the founder cells that produce the tissues and organs present in the adult worm 
are established (Sulston et al. 1983) (Figure 2.1).  This process begins soon after 
fertilization, when the zygote divides asymmetrically across the anterior-posterior axis.  
The larger anterior daughter is the first founder cell, while the smaller posterior daughter 
is the progenitor of the germline.  The germline progenitor repeats this pattern of 
asymmetric cell division three more times, eventually giving rise to six total founder cells 
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Figure 2.1.  POS-1 is required for the specification of multiple cell fates in the early C. 
elegans embryo.  A. The early C. elegans cell lineage is shown, with each founder cell 
labeled with the tissue types it produces.  The expression of POS-1 protein is shown in 
grey, and each founder cell specified incorrectly in pos-1 mutant embryos is grayed out.  
B.  Schematic of POS-1 expression in early embryos.  POS-1 expression is shown in 
grey, and each founder cell is labeled. 
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that together are the progenitors of all the tissue types present in the adult worm (Sulston 
et al. 1983).  Most cells of the zygote do not begin transcription until the four cell stage, 
and transcription does not begin in the germline lineage until just prior to gastrulation.  
(Mello et al. 1996; Seydoux et al. 1996; Seydoux and Dunn 1997).  Thus, post-
transcriptional regulation of maternal transcripts by maternal RNA-binding proteins is the 
primary mechanism that drives cell fate specification in the early embryo. 
 POS-1 is a critical trans-acting factor required for C. elegans early embryogenesis 
(Tabara et al. 1999).  POS-1 accumulates in the posterior of the fertilized zygote and is 
inherited asymmetrically at each division (Figure 2.1).  Embryos lacking POS-1 fail to 
hatch; the terminally differentiated embryos lack intestine and germ cell precursors, and 
have excess pharyngeal tissue.  Each of these tissue types is derived from a different 
founder cell, indicating that POS-1 is required for multiple cell fate specification events. 
Three genes have been identified whose expression is perturbed in pos-1 mutants:  
glp-1, apx-1 (Ogura et al. 2003), and nos-2 (D'Agostino et al. 2006).  nos-2 encodes a 
protein similar to Drosophila Nanos that is required for germ cell development and 
migration during gastrulation (Subramaniam and Seydoux 1999).  glp-1 encodes a cell 
surface receptor homologous to Drosophila Notch, and apx-1 encodes a ligand 
homologous to Drosophila Delta that is recognized by GLP-1 (Fehon et al. 1990; 
reviewed in Artavanis-Tsakonas et al. 1999). APX-1 and GLP-1 are required to pattern 
anterior development; their interaction at the two-cell stage polarizes the anterior 
blastomere as it divides, causing its posterior daughter (ABp) to adopt a hypodermal fate 
(Mello et al. 1994).  In pos-1 mutants, GLP-1 is aberrantly expressed in all cells of the 
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early embryo, while APX-1 expression is undetectable (Ogura et al. 2003).  This prevents 
polarization of the two-cell stage anterior blastomere, causing the formation of excess 
pharyngeal tissue at the expense of hypodermis.  
 The mRNA encoding glp-1 is present in every cell of the embryo until the eight-
cell stage, but GLP-1 protein is expressed only in the anterior of the embryo (Ogura et al. 
2003). The glp-1 3′ UTR is both necessary and sufficient to direct this expression pattern, 
as microinjected mRNA encoding a lacZ reporter under control of the glp-1 3′ UTR is 
expressed in a pattern identical to endogenous glp-1 (Evans et al. 1994).  This suggests 
that glp-1 mRNA is translationally repressed through its 3′ UTR in the posterior of the 
embryo.  Two seventy-nucleotide elements within the 3′ UTR, termed the spatial control 
region (SCR) and the temporal control region (TCR), are required for both spatial and 
temporal patterning.  Within the SCR are two regulatory sub-elements required for 
translational repression (glp-1 repression element, or GRE) and translational activation 
(glp-1 de-repression element, or GDE). By yeast-three hybrid, POS-1 associates with 
both the SCR and TCR, suggesting that it represses translation of glp-1 through direct 
association (Ogura et al. 2003).  However, given the complex pleiotropic phenotype of 
pos-1 mutant embryos (Tabara et al. 1999), it is unlikely that derepression of glp-1 
translation drives all of the observed patterning defects. 
 POS-1 is one of several nematode CCCH-type tandem zinc finger proteins 
(hereafter TZF) required for oocyte maturation and early development (Mello et al. 1996; 
Schubert et al. 2000; Shimada et al. 2006; Shirayama et al. 2006).  These proteins are 
related to tristetraprolin (TTP), a mammalian factor that promotes the deadenylation and 
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subsequent rapid turnover of tumor necrosis factor alpha (TNFα) mRNA by direct 
association with its 3′ UTR (Carballo et al. 1998; Lai et al. 1999; 2005).  TTP binds to the 
sequence UUAUUUAUU, present in multiple copies within the AU-rich element (ARE) 
of the TNFα 3′ UTR, with high affinity and specificity (Worthington et al. 2002; 
Blackshear et al. 2003; Brewer et al. 2004).  In contrast, the nematode TZF protein MEX-
5, required for anterior development, binds with high affinity but relaxed specificity to 
uridine-rich sequences (Schubert et al. 2000; Pagano et al. 2007).  Little is known about 
the binding specificity of the other members of the nematode TZF protein family, 
including POS-1.  To probe the basis for specific mRNA recognition by POS-1, and to 
facilitate prediction of novel POS-1 regulatory targets, we set out to delineate the RNA-
binding specificity of this protein. 
 
RESULTS 
POS-1 binds weakly to TTP and MEX-5 binding sites 
 We first asked whether POS-1 binds to RNA with the same specificity as TTP or 
MEX-5.  Recombinant POS-1 TZF domain (amino acids 80–180) was expressed as a C-
terminal fusion to maltose binding protein (MBP) in Escherichia coli and purified to near 
homogeneity.  The recombinant protein was used in quantitative electrophoretic mobility 
shift assays (EMSA) with fluorescein end-labeled RNAs encoding high affinity binding 
sequences recognized by TTP or MEX-5:  ARE13 and poly(U)-13, respectively (Brewer 
et al. 2004; Pagano et al. 2007) (Figure 2.2).  Varying concentrations of POS-1 were 
equilibrated with trace labeled RNA, and the bound RNA was resolved from the free 
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Figure 2.2.  POS-1 is a specific RNA-binding protein with a different specificity than 
either TTP or MEX-5.  A. POS-1 binding to ARE13 was measured by electrophoretic 
mobility shift assay.  A representative gel is shown, with a plot of POS-1 concentration 
versus fraction bound below.  The reported Kd, app is the average ± one standard deviation 
of three independent replicates.  B.  POS-1 binding to U13 was measured as in A.  C.  
Schematic of tiled fragments of the glp-1 SCR and TCR.  D.  POS-1 binding to fragments 
one and four of the glp-1 SCR was measured as in A.  
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RNA by gel electrophoresis.  The fraction of bound RNA at each concentration of POS-1 
was determined using a FUJI FLA-5000 fluorimager and the apparent equilibrium 
dissociation constant (Kd, app) was determined by a fit of the data to the Hill equation.  
POS-1 binds to ARE13 with modest affinity (Kd, app =  200 ± 6 nM), approximately 50 
times weaker than the previously published affinity of TTP for ARE13 (Brewer et al. 
2004).  Likewise, POS-1 binds to poly(U)-13 RNA (Kd, app = 500 ± 130 nM), but the 
affinity is reduced compared to MEX-5′s affinity for the same sequence (Pagano et al. 
2007).  Together, the results demonstrate that though POS-1 binds directly to RNA 
recognized by TTP and MEX-5, it does so with significantly reduced affinity. 
 
POS-1 binds to the 3′ UTR of multiple genes required for embryogenesis 
We hypothesized that POS-1 binds with higher affinity to a sequence determinant 
that is different from TTP or MEX-5.  In an attempt to identify a high affinity POS-1 
interacting sequence, we constructed a library of tiled fragments of the glp-1 SCR and 
TCR.  These elements were previously demonstrated to associate with POS-1 by yeast 
three hybrid analysis (Ogura et al. 2003).   Each fragment is approximately thirty 
nucleotides long and overlaps the previous fragment by fifteen nucleotides (Figure 2.2).  
The association of POS-1 with these fragments was assayed by EMSA (Figure 2.2, Table 
2.1).  POS-1 binds to three of the four SCR fragments, and to all four TCR fragments.  
The affinity of POS-1 is highest for the fragments near the 5′ end of the SCR (Kd, app = 76 
± 6), which contain the GRE and GDE.  The data indicate that one or more high affinity 
POS-1 binding sites are present in both the SCR and the TCR.  However, a comparison of  
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Table 2.1: Electrophoretic mobility shift assay with  glp-1  3' UTR fragments
Name Sequencea Kd, app (nM) n
SCR frag 1 UUAUUCUAGACUAAUAUUGUAAGCUAUAAG 76 ± 6 3
SCR frag 2 AUUGUAAGCUAUAAGUUGUAGAAUAAUUAU 97 ± 6 3
SCR frag 3 UUGUAGAAUAAUUAUUGAUCCAAAUCAGAU 120 ± 20 3
SCR frag 4 UGAUCCAAAUCAGAUUAAGAGUAUAA 500 ± 100 3
TCR frag 1 UUGUUUUUUCUCCUUUUCUUUAUAACUUGU 150 ± 20 3
TCR frag 2 UUUCUUUAUAACUUGUUACAAUUUUUGAAA 120 ± 20 3
TCR frag 3 UUACAAUUUUUGAAAUUCCCUUUUUUGACA 310 ± 30 3
TCR frag 4 UUCCCUUUUUUGACAGGCUUUUAUUACACUGUAA 189 ± 7 3  
a Boldface denotes PRE 
Each reported Kd,app is the mean ± one standard deviation of the number of replicates 
listed to the right. 
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the sequences of each fragment does not easily reveal the determinants of the high 
affinity interactions. 
 In a second approach to identify sequences that POS-1 binds with high affinity, 
we constructed a library of sequences from maternal mRNA 3′ UTRs that contain at least 
two UAUU elements (TTP half sites) with no more than two intervening nucleotides.  
We rationalized that POS-1 may bind to similar determinants as TTP, but with altered 
spacing between those determinants due to an increase in the number of amino acids that 
link the individual zinc fingers (17 in POS-1 compared to 12 in TTP).  The library was 
biased to include only UTR fragments from genes that are post-transcriptionally 
regulated during early development (Bowerman et al. 1993; Mello et al. 1994; Draper et al. 
1996; Hunter and Kenyon 1996; Gomes et al. 2001).  The affinity of POS-1 for each 
sequence in the library was assayed by EMSA (Table 2.2).  In total, six UTR fragments 
from five genes (apx-1, mex-3, pal-1, skn-1, and spn-4) were tested.  POS-1 binds to two 
of these sequences with high affinity.  These include a short fragment of the pal-1 3′-
UTR (Kd, app = 84 ± 3 nM), and a longer fragment of the mex-3 3′-UTR that contains 
multiple UAUU sequences (mex-3 fragment: 
AACUAUUAUUAUUUGUUAUUCAUAUUUU, Kd, app = 47 ± 7 nM) (Figure 2.3).   
 MEX-3 is a KH domain RNA-binding protein required for specifying the fates of 
anterior blastomeres during early embryogenesis (Draper et al., 1996).  MEX-3 acts by 
inhibiting the developmental program that specifies body wall muscle.  In wild-type 
embryos, this tissue type is produced exclusively by one of the posterior founder cells, 
while in mex-3 mutant embryos, it is produced ectopically by descendants of the two-cell  
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Table 2.2: Electrophoretic mobility shift assay with maternal mRNA fragments
Name Sequencea,b Kd, app (nM) n
apx-1  frag GUUUAUUUUUAUUAU 120 ± 10 3
pal-1  frag 1 AUUUAUUAUAUUUU 167 ± 6 3
pal-1  frag 2 CUUUAUUUAUUGU 84 ± 3 3
skn-1 frag AGUUAUUUCUAUUAU 130 ± 30 3
spn-4 frag ACGUAUUGUAUUUU 250 ± 20 3
mex-3  frag AACUAUUAUUAUUUGUUAUUCAUAUUUU 47 ± 7 3
poly(C)-15 CCCCCCCCCCCCCCC >1000 1
 
a Underline denotes TTP half site 
b Boldface denotes PRE 
Each reported Kd,app is the mean ± one standard deviation of the number of replicates 
listed to the right. 
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Figure 2.3.  POS-1 binds to the mex-3 UTR fragment with apparent 1:1 stoichiometry.  
A.  POS-1 binding to the mex-3 UTR fragment was measured as in figure 1A.  B. 
Stoichiometric binding assay between POS-1 and mex-3 RNA.  The total RNA 
concentration for the experiment is indicated.  N was determined from a quadratic fit 
(Rambo & Doudna, 2004).  C. Gel filtration chromatogram of recombinant POS-1.  Gel 
filtration standards are displayed in white.  Molecular weights of each standard peak are 
indicated.  POS-1 elution profile is displayed in grey, and the protein concentration and 
apparent molecular weight are indicated.  D. Equilibrium analytical ultracentrifugation 
traces of recombinant POS-1.  The rate of rotation, as well as the protein concentration 
for each trace is indicated.  Grey lines represent the fit to a monomer-Nmer equilibrium.  
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stage anterior daughter (Draper et al., 1996).  This suggests that MEX-3 functions during  
the same stage of embryogenesis as POS-1, and also that MEX-3 activity must be 
restricted to the anterior of the embryo.  Consistent with this, both MEX-3 protein and 
mex-3 mRNA are asymmetrically distributed in the anterior of the embryo at the two and 
four cell stages in a pattern that is anti-correlated with POS-1 (Draper et al., 1996).  POS-
1 may regulate the expression of mex-3 by repressing its translation, promoting the 
turnover of mex-3 mRNA, or both.  To further explore the potential regulatory 
relationship between POS-1 and mex-3, we decided to further characterize the interaction 
between mex-3 mRNA and POS-1.  
 
POS-1 forms an equimolar complex with the mex-3 fragment 
 POS-1 binds to the mex-3 3′ UTR fragment with the highest affinity of all tested 
sequences.  This could be due to the presence of multiple binding sites, or it might be due 
to the presence of a single site that binds to POS-1 with higher affinity.  To distinguish 
between these possibilities, the stoichiometry of the complex between POS-1 and this 
RNA fragment was determined by EMSA (Figure 2.3).  Varying concentrations of POS-1 
were equilibrated with a fixed, elevated concentration of unlabeled mex-3 RNA 
supplemented with a trace amount of fluorescently labeled mex-3 RNA.  After 
equilibration, the bound RNA was resolved from the free RNA by gel electrophoresis and 
the fraction of bound RNA was determined by fluorimetry. The data were fit to a 
quadratic model of saturable binding (Rambo and Doudna 2004).  The apparent 
stoichiometry of the POS-1:mex-3 complex is one to one (saturation point = 1.0 ± 0.1), 
 58 
consistent with the hypothesis that the mex-3 RNA contains a single, high affinity binding 
site. 
To ensure that POS-1 binds as a monomer, the oligomerization state of 
recombinant POS-1 was determined by size exclusion chromatography and by 
equilibrium sedimentation ultracentrifugation (Figure 2.3).  Both methods reveal that 
POS-1 is predominantly monomeric, even at a concentration near 20 µM, orders of 
magnitude higher than the apparent dissociation constant for the mex-3 RNA.  We 
conclude that monomeric POS-1 binds to the mex-3 3′ UTR fragment with high affinity 
as a one to one molar stoichiometric complex. 
  
POS-1 recognizes a twelve nucleotide fragment within the mex-3 UTR 
 To identify the minimal POS-1 binding site within the mex-3 3′-UTR fragment, 
three overlapping 15-nucleotide sub-fragments of this RNA were synthesized. The 
affinity of each for POS-1 was determined by EMSA (Figure 2.4).  POS-1 binds to the 
fragment #1 and #2 slightly weaker than the intact sequence (mex-3 fragment #1 Kd, app = 
110 ± 40 nM; mex-3 fragment #2 Kd, app = 89 ± 5 nM).  In contrast, POS-1 binds to 
fragment #3 with drastically reduced affinity (mex-3 framgent #3 Kd, app = 800 ± 200 nM).  
This suggests that a high affinity POS-1 binding site is located in the overlap between the 
first and second mex-3 fragments.  To test this hypothesis, a twelve nucleotide fragment 
that corresponds to this overlap (hereafter, mex-3 min) was synthesized.  This sequence 
binds with identical affinity, within error, to the original mex-3 RNA (mex-3 min Kd, app = 
39 ± 6 nM, mex-3 RNA Kd, app = 47 ± 9 nM, Figure 2.4).   
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 Figure 2.4.  POS-1 specifically recognizes a twelve nucleotide fragment of the mex-3 3′ 
UTR.  A. Table of association measurements for POS-1 and mex-3 fragments.  Kd, app was 
measured by electrophoretic mobility shift assay, and the reported values are the average 
± standard deviation for three independent replicates.  The mex-3 min sequence is 
highlighted in grey.  B. Representative electrophoretic mobility shift assay for mex-3 min.  
The fit and reported Kd, app are as in figure 1A.  C.  Representative fluorescence 
polarization assay for mex-3 min.  Each data point is the average ± standard deviation of 
five reads of an independent replicate.  The data were fit to the Hill equation, and the 
reported Kd, app is the average ± standard deviation of three independent replicates.  D.  
Representative kinetic fluorescence polarization assays for POS-1 and the indicated 
RNAs.  koff, app was determined by monitoring the change in fluorescence polarization 
after the addition of a hundred-fold excess of unlabeled competitor RNA, and fitting to a 
single exponential.  Empty circles, unlabeled mex-3 min competitor.  Filled circles, 
unlabeled C15 competitor.  Filled diamonds, no competitor.  Solid black line represents 
the single exponential fit.  
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To confirm the equilibrium dissociation constant for mex-3 min, and to develop a 
convenient assay for kinetic analysis, we assessed the ability of POS-1 to change the 
polarization of fluorescein end-labeled mex-3 min RNA in solution.  Varying 
concentrations of protein were equilibrated with limiting labeled mex-3 min RNA, and 
the polarization value determined using a fluorescence plate reader.  The association of 
POS-1 with the fluorescently labeled mex-3 min RNA significantly increases the 
polarization of the fluorophore, thus providing a parameter to monitor POS-1 binding in 
real time.  The apparent equilibrium dissociation constant was determined by plotting  
polarization as a function of protein concentration and fitting the data to the Hill equation  
(Figure 2.4).  The Kd, app of POS-1 for mex-3 RNA is 53 ± 4 nM, similar to the Kd, app 
determined by EMSA.  Next, the polarization assay was used to determine the 
dissociation kinetics of the complex.  An excess of unlabeled mex-3 min RNA, poly(C)-
15 RNA, or a buffer control was added to a pre-formed complex of POS-1 and labeled 
mex-3 min RNA (Figure 2.4).  Unlabeled mex-3 min serves as a trap to prevent 
reassociation with the labeled RNA over the time course of the experiment.  Unlabeled 
poly(C)-15 RNA does not bind to POS-1 (Table 2), and serves as a non-specific binding 
control.  To control for dissociation due to dilution, an experiment was performed with 
buffer in place of the unlabeled RNA.  The apparent dissociation rate constant (koff, app) 
was determined by fitting the observed change in polarization as a function of time to an 
exponential decay.  The koff, app is 2.94 ± 0.08 X 10-3 s-1 when unlabeled mex-3 min is used 
as a competitor.  In contrast, little dissociation is observed when poly(C)-15 or buffer 
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alone is added.  Based on these measurements, and the determination of the Kd, app above, 
the association rate constant can be calculated (kon, calc = 6.0 ± 0.4 X 104 M-1 s-1).  These 
results provide a kinetic and thermodynamic framework for detailed analysis of the 
interaction between POS-1 and the minimal mex-3 fragment.  
 
 
 
Determination of the POS-1 consensus sequence 
 Next, we set out to determine the sequence determinants within mex-3 min that 
contribute to binding.  To do this, the change in the standard free energy change (ΔΔGº) 
was measured for every single point mutation of mex-3 min RNA using EMSA.  In total, 
thirty-six individual mutations were tested, representing every possible single nucleotide 
substitution at each position of the mex-3 min sequence (Figure 2.5).  Mutation of seven 
positions causes a significant decrease in affinity (position 2–7, 10: ΔΔG > 0.5 kcal/mol), 
while five positions can tolerate any base substitution (position 1, 8, 9, 11, and 12: ΔΔG < 
0.5 kcal/mol).  Based on this data, the POS-1 recognition element (PRE) is 
UAUURDNNG, where R is any purine, D is A, G, or U, and N is any base.  Compared to 
the TTP binding site, the PRE contains an extra purine and displays a greater degree of 
degeneracy (Brewer et al. 2004).  In contrast with the MEX-5 binding sequence, the PRE 
exhibits strict requirements at several positions, while MEX-5 binds to any uridine-rich 
sequence (Pagano et al. 2007).  The disparity in specificity between POS-1, TTP, and 
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MEX-5 suggests that the POS-1-RNA interface is significantly different from those of the 
other proteins. 
 To investigate the spacing requirements between each of the purines in the PRE, 
the relative position of each purine nucleotide was varied within a polyuridine 
background, and the ΔΔGº for each mutant sequence was determined by EMSA (Figure 
2.5).  POS-1 is tolerant of an additional nucleotide between A3 and A6, and one 
additional or one fewer nucleotide between A6 and G10.  Taking the flexibility of the 
spacing between purines into account, we expand the PRE to 5′-UA(U2-3)RD(N1-3)G-3′.  
This consensus is present in all tested sequences that bind to POS-1 with high affinity, 
including fragments from the pal-1 and glp-1 3′ UTRs (pal-1 fragment #2, Kd, app = 84 ± 3 
nM and glp-1 SCR fragment #1, Kd, app = 76 ± 6 nM). 
 
 
 64 
 
 65 
Figure 2.5.  POS-1 recognizes the sequence UA(U2-3)RD(N1-3)G.  A. Systematic 
mutagenesis of mex-3 min.  The Kd, app for each mutation of mex-3 min was measured by 
electrophoretic mobility shift assay and compared to the previously measured Kd, app for 
mex-3 min to determine the change in standard change of free energy (∆∆G°).  Each bar 
represents the ∆∆G° caused by the base substitution indicated on the x-axis.  
Substitutions that cause a greater than 0.4 kcal/mol (dotted line, approximately two-fold 
difference in Kd, app) change in standard free energy are shown in dark grey.  Error bars are 
the propagation of error derived from the standard deviations of three replicates each of 
mex-3 min and the indicated base substitution.  B.  Spacing mutagenesis of mex-3 min.  
The Kd, app for a series of double mutations that switch the position of the indicated purine 
with either an upstream or downstream uracil was measured as in A.  Each bar represents 
the ∆∆G° caused by one double mutation, determined as in A.  Double mutations that 
cause a greater than 0.4 kcal/mol change in standard free energy are shown in dark grey. 
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The PRE is necessary but not sufficient to pattern the expression of a reporter 
 Published work from Marin and Evans identified a 34-nucletoide fragment of the 
glp-1 SCR that is sufficient to confer patterned embryonic expression on a reporter gene.  
Contained within this fragment are two sub-elements, the GRE and GDE, which are 
required for translational repression and de-repression of glp-1 mRNA in early embryos, 
respectively (Marin and Evans 2003).  GLD-1, a STAR-domain RNA-binding protein 
(Lee and Schedl 2001; Ryder et al. 2004) was shown to bind directly to the GRE, while it 
was unclear what trans-acting factor mediated regulation of glp-1 through the GDE 
(Marin and Evans 2003).  Surprisingly, the PRE is coincident with the GDE.  
Furthermore, a five-nucleotide substitution within the PRE prevents expression of the 
reporter protein without changing the expression of the reporter mRNA (Marin and Evans 
2003)(Figure 2.6).  This indicates that the PRE is necessary for the post-transcriptional 
regulation of glp-1 mRNA during early embryogenesis, and suggests that it may play a 
functional role in the regulation of other genes during the same period.  
To test if the PRE is sufficient to confer patterned expression to a reporter, we generated 
a strain that expresses GFP from the pie-1 promoter where six tandem copies of the mex-
3 min sequence were inserted into the pie-1 3′ UTR (Figure 2.6).  This UTR does not 
cause asymmetric expression of reporter transcripts in embryos (Reese et al. 2000), and as 
such provides a neutral background to test the role of exogenous cis-acting elements.  If 
the PRE is sufficient to cause POS-1 mediated negative regulation, we expect to see a 
GFP expression pattern that anti-correlates with POS-1.  Instead, the transgenic worms 
express GFP throughout the syncytial germline, in oocytes, and all 
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Figure 2.6. The PRE is necessary but not sufficient for patterned regulation of a reporter.  
A. 6XPRE GFP reporter strain.  Above is a schematic of the reporter construct, below is a 
widefield epifluorescence image of an adult hermaphrodite.  The oocyte region is boxed 
with a dashed line, and embryos are marked with arrows.  GFP expression is uniform 
throughout early embryos.  B. Previously published mutational analysis of the glp-1 SCR 
revealed two regulatory elements corresponding to predicted POS-1 and GLD-1 binding 
sites.  Above, schematic representation of POS-1 and GLD-1 binding sites within the glp-
1 SCR.  Below, mutations previously made within these binding sites and their 
corresponding effect on the expression of a reporter, from (Marin & Evans, 2003).  
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cells of the early embryo.  This finding suggests that the PRE alone, and thus POS-1 
binding alone, is not sufficient to drive UTR dependent regulation, and may require 
additional factors for post-transcriptional regulation of specific targets.  One likely 
accessory factor is GLD-1.  In addition to the close proximity of the PRE and GLD-1 
consensus binding sites in the glp-1 SCR, GLD-1 is co-expressed in the posterior of the 
early embryo with POS-1 (Marin and Evans 2003), and embryos depleted of GLD-1 
express GLP-1 ectopically in all cells of the early embryo (Marin and Evans 2003), in a 
pattern identical to that found in pos-1 mutant embryos (Ogura et al. 2003). Mutations 
that span both the PRE and GLD-1 consensus binding site in the SCR also cause 
ubiquitous expression of a reporter throughout the embryo (Marin and Evans 2003), 
strongly suggesting that POS-1 and GLD-1 coordinate the regulation of glp-1 in early 
embryos.  
 
Prevalence of the PRE in C. elegans 3′ UTRs 
 In order to establish a list of candidate POS-1 regulatory targets, we used the 
pattern matching tool PATSCAN to locate the PRE consensus within all annotated 3′ 
UTRs retrieved from Wormbase release WS180 (Dsouza et al. 1997).  Of the 10,201 3′ 
UTRs retrieved, 2,902 (28.4%) contain at least one POS-1 binding site.  Because POS-1 
is expressed only in early embryos, and pos-1 mutant embryos have a maternal effect 
lethal phenotype (Tabara et al. 1999), it is expected that critical POS-1 regulatory targets 
will be (1) expressed in early embryos and (2) required for early embryogenesis.  Of the 
2,902 genes that contain a predicted POS-1 binding site, 227 are expressed in one to eight 
 70 
cell embryos (Baugh et al. 2003) and result in embryos that fail to hatch when silenced by 
RNAi (Sönnichsen et al. 2005) (Figure 2.7).  GLD-1 binding sites are present in 67 of the 
227 candidate POS-1 targets, suggesting that interplay between these factors might be a 
general requirement for POS-1 mediated regulation.  We propose that these represent the 
most likely candidate POS-1 targets relevant to its roles in embryonic patterning. 
In addition to glp-1, mex-3, and pal-1, a number of genes required for establishing 
and maintaining the anterior-posterior axis (par-1, par-3 and par-5) (Cuenca et al. 2003)  
and specifying intestinal fate (mom-2, mom-5, and skn-1) (Rocheleau et al. 1997; Thorpe 
et al. 1997; Maduro and Pilgrim 1995) contain at least one PRE within their 3′ UTR.  
Intriguingly, the pos-1 3′ UTR also has a PRE, suggesting that POS-1 may play a role in 
regulating its own expression.  Neither apx-1 or nos-2, two genes whose expression 
patterns are perturbed in pos-1 mutants, contain a predicted POS-1 binding site in their 3′ 
UTRs, suggesting that the role of POS-1 in regulating these genes may be indirect.   
To determine if the POS-1 consensus sequence is statistically under-represented, we 
generated one hundred randomized artificial 3′ UTR libraries and determined the 
frequency of the PRE in each.  The artificial libraries were generated using a Markov 
chain based on the dinucleotide frequencies observed in embryonic 3′ UTRs (Figure 2.7).  
Dinucleotides were used instead of mononucleotides because a number of dinucleotides 
occurred more or less frequently than would be expected on the basis of the 
mononucleotide frequencies alone.  The average and standard deviation of the PRE 
frequency in the 100 artificial libraries establishes the expected number and variance of 
the PRE associated with random chance.  The ratio of the number of actual occurrences 
 71 
 
 72 
Figure 2.7.  The PRE is abundant in C. elegans 3′ UTRs.  A. Bioinformatics analysis of 
genes containing a PRE in their 3′ UTR.  B.  Schematic of the Markov chain used to 
generate random libraries of 3′ UTRs based on the transit probabilities measured from 
embryonic 3′ UTRs.   Each shape denotes a state, with the script B and E denoting the 
begin and end states used to model the beginning and the end of random 3′ UTRs, 
respectively.  Arrows represent the transit probabilities from the state the arrow emerges 
from to the state to which the arrow points.  Below are the measured dinucleotide transit 
probabilities of early embryonic 3′ UTRs.  Each entry represents the frequency that the 
state on the left is followed by the state above.  Values with a black background are at 
least five percent above their corresponding mononucleotide frequencies, while values 
with a grey background are at least five percent below their corresponding 
mononucleotide frequencies. 
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to the number of expected occurrences defines the extent to which the PRE is over or 
under represented. 
There are 2,314 occurrences of the PRE in the 3′ UTRs of early embryonic 
transcripts.  In contrast, there are 1530 ± 40 PRE occurrences in the set of 100 artificial 3′ 
UTRs.  Thus, the PRE is 1.51 ± 0.04 fold over-represented in real embryonic 3′-UTR 
sequences.  This finding is consistent with the hypothesis that POS-1 requires additional 
specificity factors, such as GLD-1, in order to choose appropriate targets for regulation, 
or, alternatively, that the network of targets regulated by POS-1 is much larger than 
previously anticipated. 
 
DISCUSSION 
 Using in vitro biochemical techniques, we have determined that the C. elegans 
TZF protein POS-1 is a sequence specific RNA-binding protein that binds to RNA with 
novel specificity.  POS-1 binds with highest affinity the sequence UA(U2-3)RD(N1-3)G, 
and with moderate affinity to other sequences containing ARE-like elements.  Compared 
to the related TZF proteins TTP and MEX-5, POS-1 binds to RNA with different 
specificity, demonstrating that this RNA-binding protein family is capable of binding to 
diverse sequence determinants.  TTP recognizes the sequence UUAUUUAUU (Brewer et 
al. 2004), while MEX-5 recognizes any sequence with six to eight uridines within an 
eight nucleotide window (Pagano et al. 2007).  The difference of a single amino acid in 
each zinc finger, required for specific recognition of each of the two adenosines in the 
TTP recognition element (Hudson et al. 2004), is sufficient to account for the differences 
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between TTP and MEX-5 specificity (Pagano et al. 2007).  Accordingly, the identity of 
these residues is different in POS-1 compared to either MEX-5 or TTP, suggesting that 
these amino acids also contribute to the difference in POS-1 specificity.  However, POS-
1 recognizes three purines compared to two in the TTP binding site, indicating that it 
must have a third purine recognition site.  More work, including structural studies, will be 
required to understand the molecular basis of differential RNA recognition by POS-1. 
The PRE lies within a 34-nucleotide region of the glp-1 3′ UTR that is required 
for translational regulation in early embryos (Marin and Evans 2003), and mutations that 
directly target the PRE abolish expression of a reporter gene, demonstrating  that the PRE 
is a functional cis-acting regulatory element required to pattern glp-1 expression.  
However, the PRE is not sufficient to confer POS-1 dependent regulation to an 
orthogonal 3′ UTR, indicating that additional cis-acting elements and trans-acting factors 
are required.  One likely candidate is GLD-1 (Lee and Schedl 2001; Ryder et al. 2004).  
The POS-1 binding site in the glp-1 3′ UTR is immediately adjacent to a binding site for 
GLD-1.  Mutations of either pos-1 or gld-1 result in ectopic GLP-1 expression in all cells 
of the early embryo, and mutations that disrupt the binding site for either protein lead to 
aberrant patterning of a reporter (Fig. 6A) (Marin and Evans 2003).  It is possible that 
POS-1 and GLD-1 may function as an RNA-binding complex that binds with enhanced 
specificity to only a small number of mRNAs.  If so, then maternal transcripts that 
contain binding sites for both proteins are excellent candidate targets that may contribute 
to aspects of POS-1 mediated development.   
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 The PRE occurs in the 3′ UTR of 227 genes expressed in early embryos and 
required for embryogenesis.  These include mom-2, mom-5, and skn-1, all of which are 
required for the specification of endoderm at the four-cell stage.  mom-2 and mom-5 
encode Wnt and Frizzled homologs, respectively, cell signaling factors that are required 
to induce endoderm differentiation (Thorpe et al. 1997).  skn-1 encodes a transcription 
factor that is required to activate the zygotic transcription of genes that promote 
endoderm fate (Bowerman et al. 1993; Maduro et al. 2001).  pos-1 mutants lack 
endoderm, suggesting that deregulation of some or all of these mRNAs leads to the 
failure in endoderm specification.  The PRE is also found in the 3′ UTR of par-1, par-3, 
and par-5, genes essential for the establishment of the anterior-posterior axis in the early 
embryo.  POS-1 is not translated until after the anterior-posterior axis has been 
established, which argues that it cannot play a primary role in establishing this axis.  
However, the axis must be maintained following establishment, and POS-1 could play a 
role in this pathway.  Maintenance of the anterior-posterior axis requires MEX-5 (Cuenca 
et al. 2003), which restricts the expression of POS-1 to the posterior of the early embryo.  
If POS-1 regulates par gene expression, then MEX-5 could maintain axis polarization 
through its molecular function of spatially restricting POS-1. 
The data presented here demonstrate that POS-1 binds to RNA with novel 
specificity compared to homologous TZF domain proteins, indicating that this fold can 
evolve to recognize diverse RNA sequences.  The relative simplicity of the binding 
consensus suggests a dichotomy between RNA-binding specificity and selection of 
specific mRNA targets for regulation.  The POS-1 recognition element is necessary but 
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not sufficient to confer patterned expression to a reporter, indicating that additional 
factors are involved in mRNA target selection.  The requirement for recognition by 
multiple RNA-binding proteins, each with limited sequence specificity, could explain this 
dichotomy.  Our work provides a framework for dissection of the network of maternal 
transcripts regulated by POS-1 during development, and suggests several interesting 
candidate targets that can explain the phenotypes observed in pos-1 mutants. 
 
SUPPLEMENTAL DISCUSSION 
 The highest affinity sequence identified for POS-1 in this work comes from the 
mex-3 3′ UTR to which POS-1 binds with an apparent dissociation constant of 39 nM. If 
a simple two state model correctly describes the in vivo association of POS-1 with its 
binding sites, POS-1 is uniformly distributed throughout the cytoplasm of the embryo, 
and POS-1 is present in substantial excess over its binding sites, the intracellular 
concentration of POS-1 must be at least 400 nM to achieve 90% occupancy of POS-1 
binding sites.  A C. elegans embryo can be approximated by a prolate ellipsoid with a 
minor axis of 30 µm and a major axis of 60 µM (Hillier et al. 2009), so the approximate 
volume of an embryo is 750 pL. Thus, to achieve this concentration of POS-1, at least 
200 million molecules of POS-1 protein must be present in the one-cell embryo. The total 
number of mRNA molecules within the embryo is unknown, but estimates for the 
average number of polyadenylated transcripts within each cell of the 556 cell pre-
gastrulation embryo place the number between 12,500 and 25,000 (Hillier et al. 2009). If 
mRNA turnover does not occur between fertilization and this stage, and all of these 
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transcripts are maternally supplied, the number of molecules of mRNA present within the 
one-cell embryo would be between approximately 7 million and 14 million. If pos-1 
mRNA makes up 1% of all mRNAs within the one-cell embryo – making it one of the 
most abundant mRNAs – there would be a maximum of 140,000 molecules of pos-1 
mRNA present at fertilization. Producing enough POS-1 to reach a concentration of 400 
nM would require the translation of 1500 molecules of POS-1 per mRNA molecule 
within the time it takes to complete one cell division. Based on the assumptions made 
here, this represents the minimum level of POS-1 translation required to reach this 
concentration.   
This is a very high rate of translation, so some aspect of the POS-1 localization or 
binding model is likely incorrect. POS-1 may recognize other sequences with an affinity 
much higher than that observed for the fragment from the mex-3 3′ UTR, and these 
sequences may represent the actual regulatory elements through which POS-1 functions. 
Another possibility is that the RNA-binding domain of POS-1 can have its affinity 
enhanced by other factors or post-translational modifications, which would reduce the 
amount of protein required within the embryo. A third possibility is that POS-1 is 
enriched in specific locations within the embryo, increasing the local concentration of 
POS-1 in these locations. Another RNA-binding protein with higher affinity or 
abundance may bind to mRNAs and direct them to these subcellular locations.  Thus, 
POS-1 mediated regulation of specific mRNAs may require additional upstream factors.  
In addition to its relatively low affinity for mRNA, the RNA-binding domain of 
POS-1 also exhibits an in vitro calculated association rate constant that is approximately 
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four orders of magnitude larger than the diffusion rate constant. This implies that binding 
of the RBD of POS-1 to its mRNA targets could be a slow process. As POS-1 protein is 
first translated in the one-cell embryo, the slow association of POS-1 with its targets 
could mean that binding does not occur until the two cell stage or beyond, and that other 
proteins are required to translationally repress POS-1 targets in the early embryo. 
Alternatively, the in vitro experiments described in this chapter may not fully recapitulate 
the RNA-binding properties of POS-1. Regardless, the data presented here suggest that 
there is still much to understand about POS-1 RNA-binding and the role it plays in 
regulating early embryogenesis.  
 
  
MATERIALS AND METHODS 
Cloning and of purification of POS-1 80-180 pHMTc 
 The sequence encoding amino acids 80-180 of POS-1 was amplified from the 
corresponding ORFeome (Open Biosystems) clone via PCR and cloned in frame into the 
multiple cloning site of pHMTc, a derivative of pMal-c2x (New England Biolabs) that 
includes an N-terminal 6-his tag and a TEV protease site after MBP (Ryder et al. 2004).  
This construct was transformed into and expressed in E. coli strain BL21 (DE3) Gold 
(Stratagene).  Protein expression was induced with 1 mM IPTG and 100 µM Zn(OAc)2.  
Cells were lysed and purified using an amylose column (New England Biolabs), followed 
by HiTrap SP and HiTrap Q (GE Healthcare) columns.  Purified POS-1 was dialyzed into 
storage buffer (25 mM Tris-Cl pH 8.0, 25 mM NaCl, 100 µM Zn(OAc)2, 2 mM DTT), 
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concentrated to approximately 100 µM using a 30,000 MWCO spin concentrator 
(Vivascience Group), and stored at 4 °C for up to two months. 
 
Preparation of fluorescein-5-thiosemicarbazide labeled RNA 
 All RNA oligonucleotides used in this study were chemically synthesized by 
Integrated DNA Technologies.  Oligos were fluorescently labeled at the 3′ end by 
periodate oxidation followed by reaction with fluorescein-5-thiosemicarbazide as 
described (Pagano et al. 2007). Labeled RNA was purified away from unreacted label 
using a Sephadex G-25 spin column (GE Healthcare).  Recovered RNA was assayed by 
agarose gel electrophoresis and UV-Vis spectrophotometry to determine purity and 
labeling efficiency, respectively.  Labeling efficiencies were typically around 70%.  
 
Fluorescent electrophoretic mobility shift assay 
 Varying concentrations of purified POS-1 were incubated with 3 nM fluorescently 
labeled RNA in equilibration buffer for 3 hours at room temperature.  Equilibration 
buffer contained 50 mM Tris pH 8.0, 100 mM NaCl, 0.01 mg/mL tRNA, 0.01% (v/v) 
IGEPAL, and 100 µM ZnOAc2.  After three hours, 10 µL of 0.005% (w/v) bromocresol 
green in 30% glycerol was added to 100 µL of each sample and mixed thoroughly.  50 
µL of each mixture was loaded onto a 1% agarose, 1X TB gel and run at room 
temperature for thirty-five minutes at 120 volts to resolve bound from free RNA.  Gels 
were imaged using a Fuji FLA-5000 laser imager to detect the fluorescently labeled 
RNA. The fraction of bound RNA was determined by taking the ratio of bound signal to 
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total signal.  This was plotted against the total protein concentration and fit to the Hill 
equation to determine the apparent dissociation constant: 
 
" =
( P[ ]t )n
( P[ ]t )n + (Kd ,app )n
 
where θ is the measured fraction RNA bound, [P]t is the total protein concentration, Kd, app 
is the apparent dissociation constant, and n is the Hill coefficient.  Stoichiometric binding 
assays were conducted in a similar fashion, except unlabeled RNA was added to a final 
RNA concentration of 4 µM, and the data were fit to the following equation (Rambo and 
Doudna 2004): 
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2n  
where θ and Kd, app are as above, r is the molar ratio of protein to RNA, and n is the molar 
equivalence point.  The ∆∆G˚ at 20 ˚C for each of the mutants of mex-3 min was 
determined using the following equation: 
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where R is the gas constant and T is the temperature. 
 
Gel filtration chromatography 
 The apparent molecular weight of POS-1 80-180 pHMTc relative to standards 
was determined using a Superdex 200 10/300 GL gel filtration column (GE Healthcare).  
Approximately 50 µL of 20 µM POS-1 was loaded on a column equilibrated with 50 mM 
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Tris pH 8.0, 300 mM NaCl, and the absorbance at 280 nm was monitored.  The apparent 
molecular weight of POS-1 was determined by comparing the elution volume to the 
elution volume for molecular weight standards.  
 
Equilibrium analytical ultracentrifugation 
 Three concentrations of POS-1 (8 µM, 12 µM, and 16 µM) were centrifuged at 
9,000, 12,000, and 16,000 rpm, and absorbance across the cell at 280 nm was monitored 
using a Beckman Optima XL-I analytical ultracentrifuge.  Samples were centrifuged until 
equilibrium had been reached.  The resulting traces were fit to the following equation 
describing a monomer/n-mer transition:  
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where A is the measured absorbance, a is a scaling factor, f is the fraction of protein in 
the monomeric state, ω is the angular velocity, R is the gas constant, T is the temperature, 
M is the molecular mass of the protein, n is the apparent stoichiometry of the complex, ν 
is the viscosity of solution, ρ is the density of solution, r is the cuvette radius, and r0 is a 
reference distance. 
 
Fluorescence Anisotropy Assay 
 Varying concentrations of POS-1 and 4 nM fluorescently labeled RNA were 
equilibrated as described in the electrophoretic mobility shift assay section.  Following 
equilibration, each sample was excited with linearly polarized light, and the parallel and 
perpendicular fluorescence intensities were measured five times each using a Victor3 
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1420 Multilabel Counter (Perkin-Elmer) and the apparent polarization determined.  
Polarization was plotted against total protein concentration, and fit to the Hill equation as 
above.   
 
Dissociation rate kinetics 
 Binding reactions containing 100 nM POS-1 and 4 nM fluorescently labeled mex-
3 min were equilibrated in conditions described above for thirty minutes.  Following 
equilibration, samples were transferred to a 96-well FluoTrak plate (Grenier) containing 
unlabeled competitor RNA and rapidly mixed.  Immediately following addition to 
competitor RNA, the fluorescence polarization of the sample was measured every twenty 
seconds as described above.  Fluorescence polarization measurements were plotted 
against time and fit to the following single exponential decay to determine the apparent 
dissociation rate constant:  
 
P = P0 + A " e(#koff ,app " t )  
where P is the measured fluorescence polarization, P0 is the baseline fluorescence 
polarization, A is the polarization at t=0, koff, app is the apparent dissociation rate constant, 
and t is elapsed time. 
 
Bioinformatics 
 3′ UTR sequences were retrieved from release WS180 of Wormbase 
(www.wormbase.org) using WormMart.  To avoid redundancy in the pool of sequences, 
only the longest 3′ UTR for each gene with multiple gene models was used.  The pattern 
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matching tool PATSCAN (Dsouza et al. 1997) was used to identify UTRs that contain 
POS-1 and/or GLD-1 binding sites. Mononucleotide and dinucleotide frequencies were 
determined using Perl scripts and standard UNIX text processing tools.  Random 3′ UTR 
libraries were constructed via a Markov chain; transit probabilities for each state were 
determined from the observed dinucleotide distribution and the following equation:  
(Newport and Kirschner 1982; Batchelder et al. 1999; Tadros and Lipshitz 2009) 
where pi->j is the transit probability from nucleotide i to nucleotide j, dij is the observed 
frequency of dinucleotide ij, and Di is the observed frequency of dinucleotides beginning 
with i.  
 
Error Analysis 
For electrophoretic mobility shift and fluorescence polarization assays, the 
reported value is the average of at least three independent replicates, and the error is ± 
one standard deviation.  For equilibrium sedimentation experiments, the fit error was 
determined by plotting the residuals to compare the error distribution of each fitted 
model. 
 
Reporter Strain Construction 
The reporter construct was generated by digesting plasmid pJH 4.52 (a generous 
gift of Dr. Geraldine Seydoux) with Spe1, and inserting a synthetic DNA duplex 
containing 3X copies of the mex-3 min sequence flanked by Spe1 sites.  The construct 
used for all experiments contained two copies of the insert in tandem.  The reporter strain 
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was generated by ballistic transformation using unc-119 rescue (Praitis et al. 2001).  An 
equal mixture of the reporter plasmid and pDEST-DD03, which harbors the unc-119 
rescuing fragment (a gift of Dr. Marian Walhout), was used to coat the gold particles.  
Rescued worms were analyzed for GFP expression pattern by fluorescence microscopy 
with a Zeiss Axioskop microscope. 
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Chapter III 
POS-1 represses translation of glp-1 by 
antagonizing multiple RNA-binding proteins 
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ABSTRACT 
 RNA-binding proteins (RBPs) coordinate cell fate specification and 
differentiation in variety of systems.  RNA regulation is critical during oocyte 
development and early embryogenesis, where RBPs control expression from maternal 
mRNAs encoding key cell fate determinants.  The Caenorhabditis elegans Notch 
homolog glp-1 coordinates germline progenitor cell proliferation and anterior fate 
specification in embryos.  A network of sequence-specific RBPs is required to pattern 
GLP-1 translation. Here, we map the cis-regulatory elements that guide glp-1 regulation 
by POS-1 and GLD-1.  Our results demonstrate that both proteins recognize the glp-1 3′ 
untranslated region (UTR) through adjacent, overlapping binding sites, and that POS-1 
binding excludes GLD-1 binding.  Both factors are required to repress glp-1 translation in 
the embryo, suggesting they function in parallel regulatory pathways.  Intriguingly, two 
equivalent POS-1 binding sites are present in the glp-1 3′ UTR, but only one, which 
overlaps with a translational de-repression element, is functional in vivo.  We propose 
that POS-1 regulates its targets by blocking access of other RBPs to key regulatory 
sequences, and suggest that antagonism may be a general mechanism that distinguishes 
functional from non-functional binding sites. 
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INTRODUCTION 
The physiology of a cell is governed by the identity and extent of genes that it 
expresses.  Gene expression is regulated at the transcriptional, post-transcriptional, and 
post-translational levels.  Each aspect is important and necessary to ensure appropriate 
expression for a given cell type.  The relative importance of each varies depending on cell 
lineage and activity.  For example, control of gene expression after transcription is of 
primary importance during early embryogenesis, when transcription is repressed due to 
continuous DNA replication (Newport and Kirschner 1982; Batchelder et al. 1999; 
Tadros and Lipshitz 2009), and in cells where physiology is partially decoupled from the 
nucleus due to size or morphology, such as neurons (Swanger and Bassell 2011).  In such 
situations, RNA-binding proteins and small RNA-protein complexes function as critical 
regulatory factors that control mRNA stability, subcellular localization, and translation 
efficiency to guide cell function. 
In order to coordinate gene expression, RNA-regulatory factors must select 
specific target transcripts from the set of all transcripts present in the cell.  A variety of 
high-throughput methods, including cross-linked immunoprecipitation with deep 
sequencing (HITS-CLIP, PAR-CLIP) (Licatalosi et al. 2008; Hafner et al. 2010) and RNA 
immuniprecipitation coupled with array- or deep sequencing-based detection (RIP-CHIP, 
RIP-SEQ) (Kershner and Kimble 2010; Wright et al. 2011), reveal that some RNA 
regulatory factors interact with hundreds or thousands of mRNA targets.  Though the 
number is large, it is in many cases less than one might expect based solely upon 
predictions from corresponding in vitro binding studies (Ryder et al. 2004; Bernstein et 
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al. 2005; Wright et al. 2011).  In contrast, functional assays routinely show that only a few 
RNA targets contribute to the phenotype observed upon loss of the RNA regulatory 
factor (Lee and Schedl 2001; Hansen et al. 2004; Kalchhauser et al. 2011), suggesting that 
most binding events do not directly contribute to the major phenotypes associated with 
loss of the RNA-binding protein.  The apparent disparity between in vitro binding, in vivo 
binding, and functional data reveals that the basis for specific target selection is not well 
understood. 
Post-transcriptional regulation of mRNA is primarily mediated through cis-
regulatory elements present in the untranslated regions (UTRs) of the transcript.  These 
regions are not subject to the evolutionary constraint of the genetic code and thus can 
primarily serve a regulatory role.  A survey of germline expressed genes in the nematode 
Caenorhabditis elegans demonstrates that 3′ UTRs are sufficient to drive patterned gene 
expression in the germline (Merritt et al. 2008).  Transgenic worms carrying a fluorescent 
reporter that only included the 3′ UTR of the gene being investigated recapitulated the 
expression pattern of the endogenous protein in 24 of 30 cases (Merritt et al. 2008).  In 
addition, most transcripts do not contain a unique 5′ UTR as 5′ end formation in 
nematodes is mediated primarily by trans-splicing of one of two leader sequences (Allen 
et al. 2011).  Thus, the C. elegans germline provides an ideal model system in which the 
selection of biologically relevant mRNA targets by sequence specific RNA-binding 
proteins can be examined.  
 Studies of translationally regulated transcripts in C. elegans development reveal 
that multiple RNA-binding proteins contribute to the regulation of a single mRNA 
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(Jadhav et al. 2008; Pagano et al. 2009).  One example of this is the transcript encoding 
the C. elegans Notch receptor homolog glp-1.  GLP-1 is a critical regulator of at least two 
distinct developmental pathways.  It is the central regulator of the mitosis to meiosis 
switch in the distal arm of the gonad (Austin and Kimble 1987), and it is required for 
specifying endodermal cell fates in the anterior of the four-cell embryo (Mickey et al. 
1996). GLP-1 protein is restricted to these locations in the germline and embryo (Figure 
3.1); however,  glp-1 mRNA is present throughout the entire gonad and all cells of the 
early embryo (Evans et al. 1994). glp-1 translational repression requires at least five 
different RNA-binding proteins, each repressing translation at different times during 
development:  the STAR-domain protein GLD-1 acts in germ cells entering meiosis 
(Marin and Evans 2003), the PUF family members PUF-5/6 and PUF-7 act during 
oogenesis (Lublin and Evans 2007), the KH-domain protein MEX-3 acts after fertilization 
(Pagano et al. 2009), and both GLD-1 and the CCCH-type tandem zinc finger protein 
POS-1 are required in the posterior of early embryos (Ogura et al. 2003; Marin and Evans 
2003) (Figure 3.1).  In addition, the RRM-domain protein SPN-4 is required for 
translational activation of glp-1 in the early embryo (Ogura et al. 2003).  
 Mutational analysis of the glp-1 3′ UTR has identified a 34-nucleotide region that 
is sufficient to spatially pattern a reporter (Marin and Evans 2003).  This region can be 
further subdivided into two regulatory elements: the glp-1 repression element (GRE) and 
the glp-1 de-repression element (GDE) (Marin and Evans 2003).  Mutations within the 
GRE result in an expanded reporter expression pattern in the gonad and excess reporter 
expression in the posterior of early embryos.  On the other hand, mutations of the GDE 
result in either decreased or no reporter expression in either the gonad or embryos   
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Figure 3.1.  POS-1 and GLD-1 expression is anti-correlated with GLP-1 expression.  A.  
Schematic of GLD-1 and GLP-1 expression in the germline.  GLP-1 expression (green) is 
restricted to germ cells in mitosis, while GLD-1 (red) is expressed in the meiotic 
syncytium.  GLD-1 is expressed diffusely in the cytoplasm as well as in P-body-like 
granules.  B.  Schematic of GLP-1, POS-1 and GLD-1 expression in embryos.  Embryos 
are oriented with the anterior to the left.  glp-1 mRNA (light green) is expressed in all 
cells of the early embryo, while GLP-1 protein (dark green) is not expressed until the four 
cell stage, and is restricted to the surface of the two anterior blastomeres (ABa and ABp).  
POS-1 (blue) is expressed in the posterior cytoplasm of early embryos from the one-cell 
stage.  POS-1 localizes to perinuclear P-granules in the germline P-lineage of embryos.  
GLD-1 (red) expression begins at the four-cell stage, and it is present in the two posterior 
blastomeres. GLD-1 is found in the cytoplasm, in perinuclear P-granules in the P-lineage, 
and in granules distributed throughout both cells of the four-cell stage. 
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(Marin and Evans 2003).  GLD-1 directly associates with the GRE in a sequence specific 
manner, suggesting that GLD-1 translationally represses glp-1 through the GRE (Marin 
and Evans 2003).  Given the proximity of the GDE and the GRE, it has been 
hypothesized that another RNA-binding protein inhibits GLD-1 association with the GRE 
by binding to the GDE (Marin and Evans 2003) (Figure 3.2). We previously mapped a 
binding site for POS-1 (PRE; POS-1 recognition element) (Farley et al. 2008) within the 
GDE that partially overlaps with the GLD-1 binding motif (GBM) (Wright et al. 2011) in 
the GRE, suggesting that POS-1 could function as the glp-1 activator through 
competition with GLD-1 (Figure 3.2).  In contrast, mutational studies suggest that POS-1 
acts to repress glp-1 translation, possibly in complex with GLD-1, and a different factor 
functions as the activator (Marin and Evans 2003).  Importantly, none of the mutations 
that have been made across the GRE and GDE are predicted to exclusively perturb POS-1 
binding (Figure 3.2), so it remains unclear what role POS-1 plays in regulating glp-1, or 
if regulation is direct. 
POS-1 and GLD-1 exhibit different expression patterns in the early embryo.  POS-1 is 
first observed in the posterior of the one-cell embryo, and is expressed in the posterior 
blastomeres of the embryo through the four-cell stage.  POS-1 is present throughout the 
cytoplasm of the cells in which it is expressed, as well as perinuclear granules called P-
granules in the germline precursor blastomeres (Tabara et al. 1999). In contrast, GLD-1 is 
first expressed in the posterior blastomeres of the four-cell stage, and it localizes to 
cytoplasmic granules in the cells in which it is expressed. In addition to the cytoplasmic 
granules, GLD-1 also localizes to P-granules (Jones et al. 1996) (Figure 3.1). 
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Figure 3.2.  POS-1 and GLD-1 binding sites lie within regulatory elements of the glp-1 
3′ UTR.  The glp-1 repression element (GRE) is adjacent to the glp-1 de-repression 
element (GDE, top), and both overlap with predicted POS-1 recognition elements (PRE, 
blue) and a GLD-1 binding motif (GBM, red).  Mutations across this region in the 
context of a reporter (left, above the line) result in various expression patterns, listed to 
the right.  Below the line, the mutations used in this study are listed. 
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Thus, POS-1 and GLD-1 may associate with glp-1 mRNA in different subcellular 
locations. 
To determine the individual roles of both POS-1 and GLD-1 in regulating glp-1, 
we identify separation of function mutations that individually perturb the POS-1 or GLD-
1 binding sites in vitro, and use them to generate fluorescent reporters to measure their 
relative contribution to the regulation of glp-1 expression in vivo.  The results reveal that 
POS-1 is indeed a repressor of glp-1 translation, but it acts independently of GLD-1, and 
its activity is highly context dependent. 
 
RESULTS 
Identification of a second PRE in the glp-1 3′ UTR 
 In Chapter II, we used quantitative in vitro binding studies to define the POS-1 
consensus recognition element and used the pattern matching tool PatScan (Dsouza et al. 
1997) to identify putative PREs in annotated C. elegans 3′ UTRs based upon this 
sequence (Farley et al. 2008).  This analysis revealed a single PRE in the glp-1 3′ UTR.  
However, we noticed that the search pattern does not accurately reflect the 
thermodynamic measurements in a special case where a single nucleotide deletion 
compensates for an otherwise deleterious mutation.  Specifically, mutation of the 
adenosine at position six of the PRE to a cytosine reduces binding by 0.6 kcal/mol, while 
reducing the number of intervening nucleotides between positions six and ten improves 
binding by the same amount.  When we apply the revised pattern to the glp-1 3′ UTR, we 
observe a second putative PRE that lies immediately upstream from the GBM, such that 
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the last nucleotide of the PRE corresponds to the first nucleotide of the GBM.  As such, 
the GBM is flanked by two PREs, each overlapping the GBM by one nucleotide (Figure 
3.2). 
 
POS-1 and GLD-1 recognize the glp-1 3′ UTR in a sequence-specific manner 
 To determine if POS-1 and GLD-1 recognize their predicted binding sites in the 
glp-1 3′ UTR, we performed quantitative fluorescent electrophoretic mobility shift (F-
EMSA) experiments using purified recombinant POS-1 or GLD-1 RNA binding 
domains, and a thirty four nucleotide RNA fragment of the glp-1 3′ UTR that contains 
both PREs, the GBM, and flanking sequences (Table 3.1, Figure 3.3). The fraction of 
bound RNA was plotted as a function of total protein concentration and fit to the Hill 
equation to determine the apparent dissociation constant (Kd,app) and Hill coefficient (n).  
By this method, both POS-1 and GLD-1 bind to this fragment with high affinity (POS-1:  
Kd,app = 19 ± 2 nM, n = 1.3 ± 0.2; GLD-1:  Kd,app = 70 ± 10 nM, n = 1.0 ± 0.2) (Table 3.1, 
Figure 3.3).  
 To determine if binding of each protein is dependent on its respective binding 
sites, we designed RNA oligonucleotides containing mutations in either the PREs or the 
GBM (Table 3.1, Figure 3.3).  Based on previous studies, the mutations were predicted to 
reduce the affinity of each protein for this sequence by more than 10-fold.  Mutation of 
both PREs results in an 15-fold reduction in affinity for POS-1 (Kd,app = 310 ± 20 nM), 
while mutation of the GBM results in almost complete abrogation of binding (Kd,app > 
2000 nM). Thus, both POS-1 and GLD-1 recognize the glp-1 3′ UTR in a  
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Table 3.1.  Dissociation constants of POS-1 and GLD-1 for variants of the glp-1 
fragment. 
Identifier Sequence POS-1 Kd, app 
(nM) 
GLD-1 Kd, app 
(nM) 
glp-1 WT UUUUUCUUAUUCUAGACUAAUAUUGUAAGCU 19 ± 2 70 ± 10 
∆SBE UUUUUCUUAUUCUAGACCAAUAUUGUAAGCU 21 ± 1 > 2000 
∆5' PRE UUUUUCUCCCUCUAGACUAAUAUUGUAAGCU 55 ± 4 33 ± 7 
∆3' PRE UUUUUCUUAUUCUAGACUAACCCUGUAAGCU 53 ± 1 25 ± 3 
∆5' 3' 
PRE 
UUUUUCUCCCUCUAGACUAACCCUGUAAGCU 310 ± 20 20 ± 3 
Reported Kd,app values are the mean ± one standard deviation of three independent 
replicates. 
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Figure 3.3.  POS-1 and GLD-1 recognize the glp-1 3′ UTR in a sequence-specific 
manner.  A. Schematic of mutations in the glp-1 3′ UTR.  PREs are in blue, the GBM is 
in red, and mutated sites are denoted with an X.  B.  Fluorescent electrophoretic mobility 
shift assays with recombinant POS-1 (left) and GLD-1 (right) and fluorescently labeled 
fragments of the glp-1 3′ UTR.  Top, gel shift images. Bottom,  quantifications and fits.  
POS-1 binds to the wild-type glp-1 fragment with a Kd,app = 19 ± 2 nM, mutation of 
either PRE individually reduces binding approximately 2.5-fold (∆5' PRE: Kd,app = 54 ± 
4 nM, ∆3′ PRE: Kd,app = 52 ± 1 nM), while mutation of both reduces binding 
approximately 15-fold (∆5' 3′ PRE: Kd,app = 310 ± 20 nM).  GLD-1 binds to the wild-
type glp-1 fragment with a Kd,app = 70 ± 10 nM, and mutation of the GBM almost 
completely abrogates binding (∆GBM: Kd,app > 2000 nM).  Reported Kd,app values are 
the mean ± standard deviation of three independent replicates.  
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binding site dependent manner (Figure 3B). 
 
The PREs are equivalent and independent 
 Given that only one of the PREs in the glp-1 fragment perfectly matches the 
previously published consensus, we wanted to establish if POS-1 recognized each 
binding site.  To test the contribution of each site individually, we designed 
oligonucleotides bearing mutations in only one of the PREs and performed EMSA 
experiments with recombinant POS-1.  Mutation of either PRE resulted in a 2.5-fold 
reduction in binding compared to the wild-type sequence (Kd,app WT = 19 ± 2 nM, Kd,app ∆5′ 
PRE  = 54 ± 4 nM, Kd, app ∆3′ PRE = 52 ± 1 nM), demonstrating that each site is recognized by 
POS-1 with equivalent affinity (Figure 3.3).  
 To determine if the two equivalent PREs in the glp-1 3′ UTR are independent, we 
analyzed the relationship between the macroscopic and microscopic dissociation 
constants.  An RNA with two equivalent, independent binding sites for a protein where 
only one site is occupied at any given time should have a macroscopic dissociation 
constant that is two-fold tighter than the microscopic dissociation constants observed for 
either in isolation due to statistical effects.  We observe a 2.5-fold decrease in affinity 
between the glp-1 fragments with one intact PRE versus the wild-type sequence, 
suggesting that the two PREs are both equivalent and independent.  This hypothesis is 
further supported by the unchanged Hill coefficients of the individual site mutants versus 
the wild-type sequence (nWT = 1.3 ± 0.2, n∆5′ PRE = 1.7 ± 0.5, n∆3′ PRE = 1.5 ± 0.3), as 
cooperative binding to the wild-type sequence is expected to increase the Hill coefficient.   
 101 
 
POS-1 antagonizes GLD-1 binding to the glp-1 3′ UTR 
 Given that there are two independent POS-1 binding sites that each overlap with 
the GBM, we hypothesized that POS-1 binding may inhibit GLD-1 binding to the glp-1 
3′ UTR.  To test this hypothesis, we performed in vitro competition gel shift experiments 
with POS-1 and GLD-1.  In these experiments, a range of concentrations of the 
competitor protein was titrated into a fixed, trace concentration of fluorescently labeled 
RNA, and a fixed subsaturating concentration of the other protein.  The differently bound 
species of RNA were resolved from one another by electrophoresis on a native 
polyacrylamide gel.  
 When POS-1 was titrated into samples containing 400 nM GLD-1 and labeled 
RNA, we observed a decrease in the amount of GLD-1-RNA complex and corresponding 
formation of faster mobility POS-1-RNA complex (Figure 3.4).  At high POS-1 
concentration (>300 nM), non-specific POS-1 binding obscured visibility of residual 
GLD-1 complex (Figure 4A and B).  In contrast, when GLD-1 is titrated into samples 
containing 100 nM POS-1, no GLD-1 complex is observed, even when GLD-1 is present 
at a concentration that is 10-fold greater than POS-1 (Figure 3.4).  No evidence of a 
slower mobility species is apparent, suggesting that efficient ternary complex formation 
does not happen.  Because the RNA contains two POS-1 binding sites that overlap with 
the single GLD-1 binding site, and because the apparent affinity of POS-1 is 3.5-fold 
tighter than the apparent affinity of GLD-1, this is the expected result if the proteins 
compete for binding to the RNA fragment.  Similar results were obtained when the 
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Figure 3.4.  POS-1 antagonizes GLD-1 to the glp-1 fragment.  A. Gels of competition 
experiments with POS-1 and GLD-1.  Top, POS-1 is titrated into a fixed concentration of 
GLD-1.  Bottom, GLD-1 is titrated into a fixed concentration of POS-1. The mobilities of 
POS-1-bound RNA, GLD-1-bound RNA, and free RNA are labeled to the left of the gels.  
B.  Quantifications of POS-1 1-206 competition experiments.  Left, POS-1 is titrated into 
a fixed concentration of GLD-1.  Right, GLD-1 is titrated into a fixed concentration of 
POS-1.  In both plots, fraction of total RNA bound by each protein is plotted against the 
concentration of the titrated protein. Filled circles, POS-1 bound RNA. Empty circles, 
GLD-1 bound RNA.  C-D.  Competition experiments with POS-1-RBD and GLD-1.  The 
gels in C are labeled as in A, and the plots in D are labeled as in B. 
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experiment was repeated with a shorter variant of POS-1 containing only the RNA-
binding domain (POS-1-RBD, Figure 3.4).  This construct binds to the glp-1 fragment 
with similar affinity as the longer construct (Kd,app, POS-1-RBD = 30 ± 17 nM, Figure 3.5), but 
provides greater resolution of the POS-1 and GLD-1 bound complexes.  POS-1 
efficiently competed with GLD-1 for binding to the glp-1 fragment, while GLD-1 
complex formation was strongly inhibited by POS-1.  Together, the data show that POS-1 
and GLD-1 do not simultaneously bind the glp-1 3′ UTR fragment, and suggest that POS-
1 could inhibit GLD-1 binding to the glp-1 3′ UTR in vivo.  
 
Mutations in the glp-1 3′ UTR are specific for either POS-1 or GLD-1 
 To individually determine the regulatory contribution of direct binding of POS-1 
or GLD-1 to the glp-1 3′ UTR, we designed mutants that would exclusively affect either 
POS-1 or GLD-1 binding.  To determine if the mutations designed to inhibit binding of 
either POS-1 or GLD-1 to the glp-1 3′ UTR do not interfere with the binding of the other 
protein, we used quantitative EMSA to measure the affinity of POS-1 for the ∆GBM 
version of the glp-1 fragment, and the affinity of GLD-1 for ∆5′, 3′ PRE sequence.  
Mutation of the GBM does not change the apparent affinity of POS-1 (Kd,app WT = 19 ± 2 
nM, Kd,app ∆GBM = 21 ± 1 nM), indicating that single-nucleotide GBM mutation does not 
affect POS-1 binding.  Mutation of both PREs results in a 3-fold increase in GLD-1 
affinity (Kd,app WT = 70 ± 10 nM; Kd,app ∆PRES = 20 ± 4 nM) (Figure 3.6), which is 
statistically significant (p = 0.008), suggesting that mutations in the POS-1 binding sites 
weakly increase the affinity of GLD-1 for the glp-1 3′ UTR. 
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Figure 3.5.  POS-1-RBD binds the glp-1 fragment with a similar affinity to that of POS-1 
1-206.  Top, gel shift image labeled with the POS-1 concentrations (top) in each lane, and 
the RNA sequence beneath.  The reported Kd,app is the mean ± the standard deviation of 
six separate replicates.  Bottom, representative fit of gel shift data to the Hill Equation.  
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Figure 3.6.  POS-1 or GLD-1 specific mutations in the glp-1 3′ UTR.  Left,  
representative EMSA fits for POS-1 binding to glp-1 WT RNA (filled circles, Kd,app = 
19 ± 2 nM) and ∆GBM RNA (filled triangles, Kd,app = 21 ± 1 nM). Right, representative 
EMSA fits for GLD-1 binding to glp-1 WT RNA (filled circles, Kd,app = 70 ± 10 nM) 
and ∆5' 3′ PRE RNA (open squares, Kd,app = 20 ± 4 nM). Reported Kd,app values are 
averages ± one standard deviation of three independent replicates. 
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Both POS-1 and GLD-1 binding are required for repression of glp-1 translation in 
embryos 
 To determine if direct binding of POS-1 to the glp-1 3′ UTR antagonizes GLD-1 
and thus de-represses translation glp-1 translation in early embryos, we generated green 
fluorescent protein (GFP) reporters carrying the wild-type glp-1 3′ UTR or the mutant 
variations characterized in vitro (Table 3.2).  To ensure that we were observing only the 
post-transcriptional regulation of glp-1, our reporters used the mex-5 promoter, a 
germline promoter with a similar expression pattern to the glp-1 promoter.  The open 
reading frame of each reporter encodes a protein fusion of GFP and C. elegans histone 
2B (H2B), which concentrates the fluorescent signal in the nucleus and facilitates cell 
identification.  As the half-life of both GFP and H2B is long relative to oogenesis (Frand 
et al. 2005), the open reading frame also contains the mouse ornithine decarboxylase 
PEST domain, which destabilizes the protein.  To enable direct comparison of the 
reporter expression patterns resulting from different transgenic constructs, the transgenes 
were integrated site-specifically into chromosome II using Mos1-mediated single copy 
insertion of transgenes, or MosSCI (Frøkjaer-Jensen et al. 2008) (Figure 3.7). 
 To determine the effects on reporter translation in embryos of disrupting POS-1 or 
GLD-1 binding to the glp-1 3′ UTR, we dissected adult worms and observed live four-
cell stage embryos.  Endogenous GLP-1 is expressed only in the two anterior blastomeres 
at the four-cell stage (Evans et al. 1994).  If direct binding of GLD-1 is required for 
translational repression, mutating the GBM should result in reporter expression in the 
posterior as well as the anterior of the four-cell stage embryo.  If POS-1 antagonizes 
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Figure 3.7.  POS-1 and GLD-1 binding are independently required to repress a glp-1 3′ 
UTR reporter in embryos.  A. Schematic of reporter constructs used in this study.  B.  
Representative images of four-cell embryos with the listed reporter or experimental 
condition.  C.  Table of results.  No GFP indicates the percentage of embryos with no 
detectable GFP, anterior denotes the percentage of embryos expressing GFP in the two 
anterior blastomeres, posterior denotes the percentage of embryos expressing GFP in the 
two posterior blastomeres, and n is the number of embryos observed. 
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Table 3.2.  Transgenic worm strains used in this study. 
glp-1 3' UTR 
variant 
Strain identifier Genotype 
WT WRM5 sprSi5[Pmex-5::MODC PEST:GFP:H2B::glp-1 
3'UTR cb-unc-119(+)] II, unc-119(ed3) III 
∆GBM WRM6 sprSi6[Pmex-5::MODC PEST:GFP:H2B::glp-1 
3'UTR(∆GBM) cb-unc-119(+)] II, unc-119(ed3) 
III 
∆5' PRE WRM7 sprSi7[Pmex-5::MODC PEST:GFP:H2B::glp-1 
3'UTR(∆5' PRE) cb-unc-119(+)] II, unc-119(ed3) 
III 
∆3' PRE WRM8 sprSi8[Pmex-5::MODC PEST:GFP:H2B::glp-1 
3'UTR(∆3' PRE) cb-unc-119(+)] II, unc-119(ed3) 
III 
∆5' 3' PRE WRM9 sprSi9[Pmex-5::MODC PEST:GFP:H2B::glp-1 
3'UTR(∆5' 3' PRE) cb-unc-119(+)] II, unc-
119(ed3) III 
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GLD-1 binding and thus leads to de-repression, neither anterior nor posterior expression 
of the reporter should be observed when the PREs are mutated. Expression of GFP in the 
anterior blastomeres of the four-cell stage is observed in 33% of embryos carrying the 
WT reporter, while 67% express no detectable GFP (n = 15) at this stage (Figure 3.7). 
The substantial fraction of transgene-bearing 4-cell stage embryos that lack detectable 
GFP fluorescence is likely due to the time required for maturation of the GFP 
chromophore (Reid and Flynn 1997), which is long relative to the duration of the four-
cell stage.  The anterior expression pattern matches that of endogenous GLP-1 protein, 
indicating that the glp-1 3′ UTR is sufficient for appropriate patterning and the reporter 
mimics the expression pattern of endogenous GLP-1, as previously reported (Evans et al. 
1994).  Upon treatment with pos-1(RNAi), 100% of embryos express GFP in all cells of 
the four-cell stage embryo (n = 8, Figure 3.7), suggesting that POS-1 protein plays an 
inhibitory role in the translational regulation of glp-1.  POS-1 may have indirect effects 
on the translation of glp-1, so to investigate the requirement for POS-1 binding, we 
examined a reporter with both PREs mutated. Mutation of both PREs results in a similar 
expression pattern to embryos carrying the wild-type reporter treated with pos-1(RNAi) 
(94% express in posterior, n = 16, Figure 3.7), suggesting that the PREs are required for 
translational repression rather than de-repression of glp-1, and that POS-1 directly 
regulates glp-1.  As the two PREs are equivalent and independent, we hypothesized that 
the two binding sites are redundant. To test this hypothesis and determine the individual 
contribution of each PRE, we generated transgenic strains bearing mutations in either the 
5′ or 3′ PRE.  Mutating the 5′ PRE results in embryos exhibiting wild-type GFP 
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expression (anterior  = 43%, no expression = 57%, n = 21, Figure 3.7), while mutating 
the 3′ PRE results in ubiquitously expressed GFP at the four cell stage (82% express in 
posterior, n = 27, Figure 3.7).  This suggests that despite the thermodynamic equivalence 
of the PREs in vitro, only the 3′ PRE is required for POS-1 mediated translational 
repression of glp-1.   
 Given that POS-1 binding is essential for translational repression of glp-1, and 
that GLD-1 does not bind to the glp-1 3′ UTR in the presence of POS-1 in vitro, we 
wanted to revisit the role of the GBM in embryos compared to the germline, where GLD-
1 is present but POS-1 is not.  To test this hypothesis, we generated a transgenic line 
carrying a mutation in the GBM and observed four-cell stage embryos.  Embryos 
carrying this transgene express GFP in all cells of the early embryo (87% express in 
posterior, n = 30, Figure 3.7) suggesting that the GBM is also required for translational 
repression of glp-1 in the embryo.  This matches the previously published results for both 
the endogenous GLP-1 expression pattern in gld-1(RNAi) embryos (Marin and Evans 
2003), as well as for reporters carrying mutations in the GRE (Marin and Evans 2003), 
confirming that GLD-1 acts through the GRE to repress glp-1 translation in the embryo.  
 
The 3′ PRE mutations disrupt the GDE in the germline 
 The 3′ PRE mutation lies entirely within the GDE, which is required for 
translational activation of glp-1, but results in delocalized expression in the embryo.  We 
wanted to determine the effect of the PRE mutations on germline expression of the glp-1 
reporter.  The gonads of live worms were observed by widefield fluorescence microscopy 
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(Figure 3.8). Worms carrying the wild-type reporter have strong GFP expression in the 
distal end of the germline, with diminishing expression in the syncytial region (95% 
strong distal expression, 85% weak syncytial expression, n = 20, Figure 3.8).  This 
closely matches the expression of endogenous GLP-1 in the germline.  Mutation of the 5′ 
PRE has no effect on expression of GFP, consistent with the effects observed in embryos 
(86% strong distal expression, 89% weak syncytial expression, n = 28, Figures 6B, 6C).  
Mutation of both the 5′ PRE and 3′ PRE, or just the 3′ PRE alone results in decreased 
reporter expression in the germline relative to the wild type reporter (∆5′PRE 3′PRE: 
70% weak distal, 100% no syncytial, n = 27; ∆3′PRE: 96% weak distal, 80% no 
syncytial, n = 25, Figure 3.8).  This apparent decrease is not dependent on POS-1, as pos-
1(RNAi) has no apparent effect on expression of the wild-type reporter in the germline 
(100% strong distal, 100% weak syncytial, n = 9, Figure 3.8).  Taken together, this 
suggests that the 3′ PRE mutation also disrupts the association of a factor required for 
activation of glp-1 translation in the germline.  The GBM is required for translational 
repression of glp-1 in the syncytial region, as a reporter carrying a mutation in the GBM 
displays increased expression of GFP in the syncytial region of the germline (85% strong 
distal, 65% strong syncytial, n = 25, Figure 3.8).   
 
SPN-4 does not directly activate glp-1 translation in the germline 
 The RRM-containing protein SPN-4 is a potential candidate for the activating 
factor that operates through the GDE in early embryos.  SPN-4 is expressed throughout 
all cells of  the embryo during the four cell-stage (Ogura et al. 2003), and GLP-1 
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Figure 3.8.  Mutation of the 3′ PRE decreases glp-1 reporter expression independently of 
POS-1.  A.  Schematic of the C. elegans gonad.  Distal and syncytial regions are labeled. 
B. Representative differential interference contrast (DIC, left) and widefield fluorescence 
(GFP, right) images of the listed reporter strains or experimental condition.  White 
asterisks mark the distal end of the gonad, white arrows mark decreased reporter 
expression in the distal region of ∆5' 3′ PRE and ∆3′ PRE reporter strains, white 
arrowheads mark increased reporter expression in the embryos of ∆5' 3′ PRE and pos-
1(RNAi) treated WT reporter strains, and the black arrowhead marks increased reporter 
expression in the syncytium of the ∆GBM reporter strain.  C. Table of results.  Distal and 
syncytial refer to their respective regions of the gonad, and black percentages represent 
the most common observation for each strain in both the distal and syncytial regions of 
the gonad. 
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expression is undetectable in embryos lacking SPN-4 (Ogura et al. 2003). Also, SPN-4 
and POS-1 compete for binding to the nos-2 3′ UTR in vitro (Jadhav et al. 2008). To 
determine if SPN-4 activates expression of the glp-1 3′-UTR reporter, we observed the 
pattern of GFP expression in four cell embryos as a function of SPN-4 knockdown.  
Anterior expression of GFP is observed in 48% of untreated 4-cell embryos carrying the 
glp-1 WT  reporter (n = 28, Figure 3.9), while only 11% of spn-4(RNAi) 4-cell embryos 
had detectable GFP in the anterior cells (n = 38).  This suggests that SPN-4 is indeed 
required to activate expression from the glp-1 3′UTR reporter in the early embryo.  
However, this activation is not mediated through the GDE, as SPN-4 knockdown has no 
effect on GFP expression in 4-cell embryos carrying a reporter bearing the ∆3′ PRE 
mutation (∆3′ PRE: 100% of embryos have anterior and posterior GFP expression, n = 
30; ∆3′ PRE spn-4(RNAi): 93% of embryos have anterior GFP expression and 97% have 
posterior GFP expression, n = 30, Figure 3.9).  Furthermore, purified SPN-4-RBD does 
not bind to either the glp-1 fragment (Figure 3.9) or a longer RNA containing the entire 
glp-1 GDE (data not shown) in vitro.  Thus, SPN-4 is not likely to compete with POS-1 
for binding to the GDE.  Consistent with this interpretation, SPN-4 was previously 
observed to interact with a distant element of the glp-1 3′-UTR by yeast 3-hybrid. (Ogura 
et al. 2003). 
 Taken together, consistent with previous work, we conclude that translational 
control of glp-1 requires both repressive and activating elements.  GLD-1 binds to the 
GRE and is required for repression.  POS-1 also binds to the GRE in vitro, but binding to 
the GRE has no effect on glp-1 expression in worms.  In contrast, POS-1 binds with 
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Figure 3.9.  SPN-4 activates glp-1 translation indirectly.  A.  Representative images of 
four-cell embryos carrying the listed reporter construct (left), and treated as described 
(top).  Bottom, table of results.  Anterior and posterior denote the percentage of 4-cell 
embryos with detectable GFP fluorescence in either the anterior or posterior cells, 
respective.  None denotes the percentage of embryos with no detectable GFP 
fluorescence.  B.  Representative gel shift data for SPN-4-RBD.  The protein 
concentration used in each lane is labeled above the gel.  
 121 
equivalent affinity to the GDE in vitro, but binding is required for repression, not 
activation.  We suggest that POS-1 represses translation by competing with an 
unidentified factor that binds to the GDE to promote translation.  This would explain why 
two thermodynamically equivalent POS-1 binding sites, separated by only five 
nucleotides, contribute disparately to glp-1 regulation, and why the PRE is necessary but 
not sufficient to confer regulation in worms. 
 
DISCUSSION 
 Our data show that POS-1 and GLD-1 directly and independently repress glp-1 
translation in the early embryo.  Independent regulation of glp-1 may be a consequence 
of the differing spatial, temporal, and subcellular localization patterns of each protein. As 
POS-1 is expressed earlier than GLD-1 (Tabara et al. 1999; Jones et al. 1996), glp-1 is 
likely regulated only by POS-1 during the one- and two-cell stages.  Once GLD-1 
translation begins, it may become the primary negative regulator of glp-1. As POS-1 
antagonizes binding of GLD-1 to the glp-1 3′ UTR, the handoff to GLD-1 mediated 
repression would likely require inactivation or turnover of POS-1. Alternatively, the 
differences in subcellular localization between POS-1 and GLD-1 may be indicative of 
different mechanisms of glp-1 repression.  In the germline, GLD-1 is present in P-body 
like granules (Noble et al. 2008), but it is unknown if the GLD-1 granules in the embryo 
are also P-bodies. As P-bodies are sites of mRNA decapping and turnover, GLD-1 may 
promote turnover of glp-1 mRNA in the embryo.  Thus, binding to either POS-1 or GLD-
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1 may lead to different regulatory outcomes, and competition between these two proteins 
may be essential for controlling the rate of glp-1 mRNA turnover.  
Our data suggests that a third factor that promotes glp-1 translation competes with 
both POS-1 and GLD-1 for binding to the GRE and GDE.  One candidate is the atypical 
cytoplasmic poly(A) polymerase GLD-2, which is expressed throughout the germline and 
embryo and is required for development (Wang et al. 2002).  GLD-2 lacks an RNA-
binding domain, and requires the association of an RNA-binding protein to target the 
polymerase to specific transcripts and extend the poly(A) tail, activating translation.  At 
least two such accessory factors (GLD-3 and RNP-8) are expressed throughout early 
embryos (Suh et al. 2006; Kim et al. 2010).  When GLD-1 or POS-1 levels are low, for 
example in the anterior blastomeres ABa and ABp, GLD-2 may stimulate 
polyadenylation of glp-1 transcripts, leading to translation activation. It is also possible 
that translational activation of glp-1 could be mediated by sequence-specific factors that 
recognize the GDE but do not recruit GLD-2.  More work is needed to identify the 
activating protein and dissect the mechanism of activation. 
During early embryogenesis, numerous maternally supplied mRNAs encoding 
cell-fate specification factors are translationally regulated.  Mis-expression of these 
factors can lead to mis-specification of cell fates, and ultimately embryonic lethality.  
Several RNA-binding proteins are present in different amounts in each blastomere of the 
early embryo.  Competition between positive and negative regulatory factors would 
couple the amount of protein produced to the relative ratio of RNA-binding proteins in 
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each cell, providing a mechanism to drive cell specific expression of cell fate 
determinants.    
Clusters of overlapping binding sites are a required component of this competition 
model. To identify clusters of binding sites, a detailed understanding of RNA-binding 
factor motifs is required.  Intriguingly, the motifs recognized by POS-1, GLD-1, and a 
third embryonic RNA-binding protein, MEX-3, include partially overlapping elements 
(Farley et al. 2008; Wright et al. 2011; Pagano et al. 2009).    Thus, clustering of binding 
sites is a natural outcome of their evolved specificity.   
 Another feature of the competition model is that RNA-binding proteins exist that 
do not recruit regulatory machinery, but instead antagonize other factors that do.  We 
propose that POS-1 acts by this mechanism.  Our model is supported by the inability of 
PREs to pattern a reporter (Farley et al. 2008), as well as the context dependence of the 
PRE required for glp-1 regulation in vivo.  PREs are present in over 40% of annotated 3′ 
UTRs (Farley et al. 2008), but  we predict many putative binding events serve no 
biological function.  Thus, the apparent dichotomy between biologically relevant 
specificity and thermodynamic discrimination by RNA-regulatory factors could possibly 
be explained by antagonistic relationships between multiple proteins.   
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MATERIALS AND METHODS 
Cloning and purification of POS-1, GLD-1 and SPN-4 
 DNA encoding amino acids 1-206 of POS-1 cloned into the protein expression 
vector pMAL-c2x (New England Biolabs) was graciously provided by Dr. Tom Evans 
(U. of Colorado Anshutz Medical Campus, Aurora, CO).  The plasmid was transformed 
into E. coli strain BL21 (DE3).  Protein expression was induced with 1 mM IPTG and 
100 µM Zn(OAc)2.  The cells were lysed using a microfluidizer, and the lysate was 
purified using an amylose column (New England Biolabs), followed by a Source Q 
column (GE Healthcare Life Sciences) and a HiPrep 16/60 Sephacryl S-200 column (GE 
Healthcare Life Sciences). After the final column, the protein was dialyzed into 25 mM 
Tris pH 8.0, 25 mM NaCl, 2 mM DTT, 100 µM Zn(OAc)2, concentrated to 
approximately 30 µM, and used for experiments. 
  DNA encoding amino acids 50-135 of SPN-4 was cloned into the protein 
expression vector pHMTc (Ryder et al. 2004) and transformed into E. coli strain BL21 
(DE3), and induced as POS-1 1-206 above, omitting the zinc acetate.  Cells were lysed 
using a microfluidizer, and the lysate purified using an amylose column (New England 
Biolabs), followed by a HiTrap SP HP column (GE Healthcare Life Sciences) and a 
SourceQ column (GE Healthcare Life Sciences). Following the last column, the protein 
was dialyzed into 25 mM Tris pH 8.0, 25 mM NaCl, 2 mM DTT, concentrated to 
approximately 20 µM, and used for experiments.  
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POS-1-RBD was expressed and purified from pHMTc-POS-1(80-180) as 
described in (Farley et al. 2008).  GLD-1 was expressed and purified from pHMTc-
GLD1(135-336) as described in (Ryder et al. 2004). 
 
Fluorescent labeling of RNAs 
 RNA oligonucleotides were synthesized by Integrated DNA Technologies and 
fluorescently labeled on their 3′ ends via periodate oxidation followed by reaction with 
fluorescein-5-thiosemicarbazide (Sigma).  Unreacted label was purified away via G-25 
spin column. A detailed protocol is available in (Pagano et al. 2011). 
 
Fluorescent electrophoretic mobility shift assays 
 Fluorescent electrophoretic mobility shift assays were essentially performed and 
analyzed as described in (Pagano et al. 2011).  Briefly, 2 nM fluorescently labeled RNA 
in equilibration buffer (50 mM Tris pH 8.0, 100 mM NaCl, 5 µM Zn(OAc)2, 0.01% 
IGEPAL CA-630, 0.01 mg/mL tRNA) was mixed with varying concentrations of either 
POS-1 or GLD-1 and equilibrated at room temperature for three hours.  The protein-
bound and free RNA was then resolved on a 1X TB native 5% polyacrylamide slab gel 
run at 120 volts for approximately one hour at 4 ºC.   
Competition assays were performed in essentially the same fashion, except a fixed 
concentration of POS-1 or GLD-1 was added to the labeled RNA in equilibration buffer 
to achieve approximately 70% bound RNA in the absence of competitor protein.  Then, 
varying amounts of competitor protein were added to each reaction and incubated for at 
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least three hours.  The reactions were then loaded onto a 1X TB native 5% 
polyacrylamide slab gel run at 120 volts for three hours at 4ºC to resolve POS-1 and 
GLD-1 bound complexes.  Gels were quantified using Image Gauge (Fuji), and the 
fraction of protein bound RNA was determined by quantifying the ratio of the 
background corrected pixel intensity of the protein-bound RNA relative to the sum of the 
background corrected pixel intensities of each RNA species.  Two independent replicates 
of each competition experiment involving POS-1 were performed, and five independent 
replicates were performed with POS-1-RBD.  
 
Cloning of reporter constructs 
 The glp-1 3′ UTR was amplified via PCR using Elongase (Invitrogen) from worm 
genomic DNA using primers that added the attB2R and attB3 sites to the 5′ and 3′ ends of 
the product, respectively. The PCR product was then cloned into pDONRP2RP3 using 
BP Clonase II (Invitrogen). Site-specific mutations in the glp-1 3′ UTR were introduced 
via Quickchange mutagenesis using Pfu Turbo.  Each of the resulting variants of the glp-
1 3′ UTR was then used in a multi-site gateway reaction with plasmids bearing the mex-5 
promoter (pCM1.111) and MODC PEST::GFP::H2B ORF (pBMF2.7) to generate 
constructs for integration. The gateway reaction was catalyzed with LR Clonase II Plus 
(Invitrogen), and the promoter::ORF::3′ UTR fusions were cloned into the MosSCI 
integration vector pCFJ151.  
 
Generation and verification of transgenic strains 
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 Single copy integrated transgenic worms strains were generated by MosSCI 
(Frøkjaer-Jensen et al. 2008).  Plasmids bearing the transgene to be integrated were 
microinjected into the gonads of young adult worms of strain EG4322 along with 
pharyngeal- and body wall-expressed mCherry markers and a constiutive germline-
expressed Mos1 transposase.  Prior to injection, worms were maintained at 15 ºC on 
NGM agar plates seeded with Comamonas (DA1877).  Worms were propagated for two 
generations, and screened for successful integration by checking for wild-type movement 
without expression of the mCherry extra-chromosomal array markers.  Putative integrants 
were confirmed by PCR using a transgene specific primer and a worm genome specific 
primer. These PCR products were then sequenced to validate the mutations in the 
reporter's 3′ UTR.  
 
Imaging of fluorescent reporter strains 
 Prior to imaging, worms were maintained at 25 ºC for at least 24 hours to promote 
GFP folding.  Embryos were obtained by dissecting adult worms and then mounted on 
2% agarose pads, and whole worms were paralyzed with 0.4 mM levamisole and 
mounted on 2% agarose pads.  Both DIC and GFP images were collected using a Zeiss 
Axioskop microscope.  
  
RNAi knockdown 
 Embryos were harvested from adult worms by treatment with 0.5 N NaOH and 
2% Clorox bleach, washed twice with water, and then transferred to NGM plates seeded 
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with bacteria expressing dsRNA targeting either POS-1 or SPN-4.  Worms were 
maintained at 25 ºC and imaged as described above.  
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Chapter IV 
The ramifications of promiscuous RNA 
binding specificity 
 131 
 The goal of the research presented within this dissertation is to identify the direct 
mRNA regulatory targets of the C. elegans CCCH-type tandem zinc finger protein POS-1 
by determining its in vitro RNA-binding specificity and using this information to predict 
in vivo regulatory targets.  Embryos lacking POS-1 fail to complete gastrulation, and the 
arrested embryos exhibit severe defects in three spatially distinct tissue types: pharynx, 
intestine, and germline precursors.  Identifying the regulatory targets of POS-1 could 
provide insight on the biological pathways that guide cell fate specification events during 
embryogenesis as well as the mechanism of maintaining the distinction between germline 
and somatic identities during embryogenesis.  
 Based on the results presented here, POS-1 recognizes a degenerate sequence that 
is present in the 3′ UTRs of approximately 40% of all genes in the C. elegans genome.  
Two POS-1 binding sites are located within 5 nucleotides of each other within the 3′ 
UTR of glp-1, a known regulatory target of POS-1.  These binding sites overlap with two 
previously characterized regulatory elements within the glp-1 3′ UTR: the glp-1 
repression element (GRE) and glp-1 de-repression element (GDE).  POS-1 recognizes 
each of these sites with equivalent affinity in vitro, but only the 3′ POS-1 binding site is 
required for translational repression in embryos.  Mutation of both sites or just the 3′ 
POS-1 binding site results in decreased reporter expression in the germline that is 
independent of POS-1, suggesting that a factor required to activate translation binds to 
the glp-1 3′ UTR through this site.  It is therefore possible that POS-1 regulates its targets 
not by recruiting regulatory machinery, but instead by interfering with the association of 
other RNA-binding proteins that do.  
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 In addition to sites for POS-1, this region of the glp-1 3′ UTR contains a binding 
site for GLD-1, which is required to repress translation of glp-1 in the distal germline as 
well as the posterior of the early embryo.  GLD-1 acts through the GRE, and mutation of 
this site within the context of a reporter results in expanded reporter expression in the 
gonad as well as reporter expression within the posterior of the early embryo.  This, 
together with the requirement for POS-1 and the unidentified activating factor, indicates 
that multiple RNA-binding proteins each require this fragment of the glp-1 3′ UTR for 
different regulatory pathways.  
 
POS-1 specificity 
 One potential model for how POS-1 regulates a limited subset of targets involves 
competition with other RNA-binding proteins. POS-1 itself may not recruit translational 
repression machinery, but instead interfere with the association of translation-activating 
factors. This model is supported by the two POS-1 binding sites within the glp-1 3′ UTR.  
POS-1 binds to each of these sites with an equivalent affinity in vitro, but only the 3′ 
POS-1 site is required for translational repression of a reporter in vivo.  The 3′ POS-1 site 
is coincident with the GDE, mutations of which result in either less or no expression of a 
reporter relative to a wild-type sequence.  Another RNA-binding protein required for 
translational activation of glp-1 may act through the GDE, which overlaps with the 3′ 
POS-1 binding site, but not the 5′ POS-1 binding site.  If this is the case, binding of POS-
1 to the 3′ site would prevent the association of the activating factor and serve to repress 
translation of glp-1.  In this scenario, POS-1 would not need to recruit any negative 
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regulatory machinery to the glp-1 3′ UTR to elicit translational repression. Instead, 
binding to a site required by another regulatory factor and inhibiting its association would 
suffice.   
 As a result of this model, the functionality of POS-1 binding sites would depend 
on which, if any, factors associated nearby.  Many of the predicted POS-1 binding sites 
throughout C. elegans 3′ UTRs may be non-functional because binding of POS-1 to these 
sites would not interfere with another regulatory factor.  The requirement that POS-1 
binding competes with another RNA-binding protein for regulation would greatly 
increase the target specificity of POS-1, as only a limited subset of POS-1 sites would 
overlap with or be in close proximity to those of another protein.  Understanding which 
POS-1 binding sites are functional regulatory elements requires the identification of 
which factors POS-1 competes with for binding to specific sites across C. elegans 3′ 
UTRs.  
 There are two possible groups of RNA-binding proteins that POS-1 may compete 
with to regulate its targets: the atypical cytoplasmic poly(A) polymerases, and the other 
CCCH-type tandem zinc finger proteins that are present in C. elegans.  Poly(A) tails are 
generally required for translation, as poly(A) binding protein (PABP) recruits the 
translation initiation factor EIF4G, which binds to the 5′ cap binding protein EIF4E and 
permits the assembly of the 80S ribosome at the 5′ end of the transcript.  Removal or 
shortening of the poly(A) tail prevents PABP binding, which in turn prevents the 
formation of the translation initiation complex and results in translational repression.  
mRNAs transcribed in the germline that are destined for translation in the embryo are 
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frequently translationally repressed by this mechanism. Shortened poly(A) tails can be 
extended in the cytoplasm by cytoplasmic poly(A) polymerases, which permits 
translation.  Two cytoplasmic poly(A) polymerases have been identified in C. elegans: 
GLD-2 and GLD-4 (Wang et al. 2002; Schmid et al. 2009).  Both of these proteins are 
expressed in the germline and in developing oocytes, and each is required for meiotic 
progression in the distal end of the germline.  Unlike most poly(A) polymerases, GLD-2 
and GLD-4 contain only a catalytic domain and require the association of an RNA-
binding protein to be targeted to mRNA.  GLD-2 associates with either the KH-domain 
protein GLD-3 or the RNA-recognition motif containing protein RNP-8 (Wang et al. 
2002; Kim et al. 2010), while GLD-4 associates with either GLD-3 or the novel P-granule 
component GLS-1 (Rybarska et al. 2009).  The mRNAs that either poly(A) polymerase 
are targeted to changes based upon the associated specificity factor.  Any of these 
poly(A) polymerases or specificity factors may be required to activate the translation of 
glp-1 or other potential POS-1 targets in the germline or early embryo.  As the RNA-
binding specificities of GLD-3, GLS-1, and RNP-8 are unknown, it is difficult to 
determine if any of these factors have potentially overlapping specificities with POS-1.  
 Another group of candidate factors that may have positive regulatory roles and 
compete with POS-1 for binding to mRNA targets are the other members of the C. 
elegans CCCH-type tandem zinc finger family of RNA-binding proteins.  The C. elegans 
genome contains 16 CCCH-type TZF proteins (reviewed by Kaymak et al. 2010). 8 of 
these proteins are required for oogenesis or embryogenesis, while the functions of the 
other 8 are largely unknown.  Members of the CCCH-type TZF family display a range of 
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distinct but related sequence specificities: the mammalian homologs TTP and Tis11d 
recognize the sequence UAUUUAUU with high affinity and specificity (Hudson et al. 
2004; Brewer et al. 2004), POS-1 recognizes the sequence UAU2-3RDN1-3G with high 
affinity, and MEX-5 is capable of binding to U-rich sequences (Pagano et al. 2007). It is 
possible that one of the other C. elegans CCCH-type TZF proteins recognizes a similar, 
but not identical sequence to that of POS-1.  Given this similarity in specificity, there 
would be a significant number of sites that could be recognized by both proteins.  If one 
of the other CCCH-type tandem zinc finger proteins recruits positive regulatory 
machinery, it could serve as a competitive activator of POS-1 bound mRNAs.  One 
potential TZF protein is DCT-13, which partially suppresses the gld-1(-) phenotype of a 
mitotically proliferating germline tumor (Pinkston-Gosse and Kenyon 2007).  As mitotic 
proliferation of germ cell precursors depends upon GLP-1 activity, tumor suppression 
may be mediated by a decrease in the levels of GLP-1.  The level of GLP-1 expression in 
either a dct-13(-) or gld-1(-);dct-13(-) background has not been investigated, and could 
prove to implicate DCT-13 in glp-1 translational activation.  
 It is also possible that neither of these groups of factors acts to activate the 
translation of glp-1 or other mRNAs that are also bound by POS-1.  The 3′ half of the 
POS-1 recognition sequence is only weakly specific (UAU2-3R versus DN1-3G), which 
may facilitate overlapping binding sites with a variety of RNA-binding proteins with 
differing specificities. The glp-1 3′ UTR presents a system in which these competing 
factors – if any – can be identified.  Using the reporter strains already generated over the 
course of this dissertation research, nucleotide capture experiments can be performed that 
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specifically recover reporter mRNAs (by designing capturing oligos that are 
complimentary to the coding sequence of GFP).  If the samples are crosslinked via UV or 
formaldehyde treatment prior to recovery, the suite of proteins associated with the 
reporter mRNA can be recovered with it, and these can be identified via proteomic 
methods.  Comparing the ensemble of proteins associated with the reporter bearing the 
wild-type glp-1 3′ UTR or a version carrying a mutation in the 3′ PRE would permit the 
identification of proteins that differentially associate with the glp-1 3′ UTR as a function 
of the 3′ PRE. Once identified, in vitro biochemical analysis could be performed to verify 
that the putative RNA-binding proteins associate with the glp-1 3′ UTR in a POS-1 
binding site dependent manner.  This approach would permit the identification of new 
glp-1 3′ UTR associated factors in a model independent manner, and could offer new 
insights on the mechanism of POS-1 mediated translational repression. 
 
Translational regulation of glp-1 
 The data presented in this dissertation support the hypothesis that glp-1 is 
translationally repressed via two separate pathways during C. elegans embryogenesis. 
One pathway requires POS-1 and is mediated through the 3′ PRE in the glp-1 3′ UTR, 
while the other pathway requires GLD-1 and is mediated through the SBE. Mutations in 
either binding site result in reporter expression in the posterior of the four-cell embryo, 
demonstrating that each protein is required for translational repression in the posterior 
cells.  In vitro competition experiments suggest that POS-1 competes with GLD-1 for 
binding to the glp-1 3′ UTR. Furthermore, the footprint of GLD-1 when bound to RNA is 
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more than 20 nucleotides, making it extremely unlikely that both proteins can bind 
simultaneously in vitro or in vivo. A co-regulatory complex of POS-1 and GLD-1 
requires that both proteins bind together, and is thus not probable.  On, the other hand, if 
POS-1 and GLD-1 are redundant translational repressors of glp-1, mutation of either the 
SBE or 3′ PRE should not be sufficient to cause de-repression of a reporter as the non-
mutated site could still mediate repression. Neither of these models is correct, as both 
POS-1 mediated repression and GLD-1 mediated repression are required in the embryo.  
 One possibility for the requirement of both proteins is that each is required in a 
separate sub-cellular location within the embryo.  The reporter constructs used in these 
experiments contains histone 2B, which directs GFP to the nucleus regardless of where in 
the cell translation takes place.  Immunofluorescence of either POS-1 or GLD-1 reveals 
that the two proteins have different expression patterns within the cells in which they are 
expressed. POS-1 is distributed throughout the cytoplasm of the cells in which it is 
expressed (Tabara et al. 1999), while GLD-1 is predominantly localized to cytoplasmic 
granules (Jones et al. 1996). This localization is observed in both embryos and the 
syncytial region of the germline, where GLD-1 is also expressed and serves to 
translationally repress multiple targets.  These cytoplasmic granules contain numerous 
mRNAs as well as other RNA-binding proteins. Two proteins in particular are required 
for the stability of the cytoplasmic granules in the germline: CGH-1 and CAR-1 (Noble et 
al. 2008).  Mutation of the gene encoding either one of these proteins results in the 
disappearance of cytoplasmic granules in the syncytium of the germline, as well as a 
significant decrease in the expression level of mRNAs that are normally contained within 
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the granules (Noble et al. 2008; Scheckel et al. 2012).  mRNAs targeted to these granules 
are translationally repressed but also stabilized, suggesting that these granules are for the 
storage of mRNAs required in embryogenesis.  GLD-1 may serve to translationally 
repress mRNAs that are localized to these storage bodies. glp-1 mRNA is contained 
within the granules in the germline, and the glp-1 3′ UTR is sufficient for localization 
(Noble et al. 2008).  A similar mechanism may be taking place in the embryo, generating 
two distinct pools of glp-1 mRNA: one within the cytoplasm, and one within cytoplasmic 
granules.  POS-1 may be the primary factor required for translational repression within 
the cytoplasm, while GLD-1 may be the primary repressor in granules, which would 
make each protein necessary for translational repression within embryos.  
 POS-1 and GLD-1 are just two of the RNA-binding proteins required to 
translationally repress glp-1 in the germline and early embryo.  PUF-5, PUF-6, and PUF-
7 are required in the region of the gonad where oocytes recellularize (Lublin and Evans 
2007), OMA-1/2 may be required in maturing oocytes, and MEX-3 is required in one-cell 
embryos (Pagano et al. 2009).  The specificity of MEX-3 is known, and most members of 
the PUF family of proteins recognize a sequence that contains a UGU trinucleotide with 
an UA dinucleotide close downstream.  Investigating the glp-1 3′ UTR for these 
sequences reveals an approximately 100 nucleotide fragment that contains two MEX-3 
sites, three candidate PUF-protein sites, and the POS-1 and GLD-1 sites previously 
described (Figure 4.1). In addition, this fragment is well conserved across closely related 
nematode species, suggesting that it may be a functional regulatory element.  The RNA-
binding specificity of OMA-1/2 is unknown, but preliminary experiments suggest that it 
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Figure 4.1.  A cluster of binding sites is present in the glp-1 3′ UTR.  An image from the 
UCSC genome browser with predicted binding sites for POS-1, GLD-1, MEX-3, and 
PUF-like consensus sequences annotated.  Top, binding site predictions. Middle, glp-1 3′ 
UTR annotation. Bottom, nucleotide conservation as determined by the PhastCons 
algorithm. Higher bars within the histogram indicate greater conservation. 
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too is a direct translational repressior of glp-1 and that it acts through an unidentified 
sequence within this cluster of binding sites (E. Kaymak, unpublished data).  Clusters of 
sites for multiple RNA-binding proteins may be indicative of a functional regulatory 
element, especially in light of the proposed mechanism of POS-1-mediated translational 
repression.  Identifying clusters of binding sites requires an understanding of the RNA-
binding specificity of multiple RNA-binding proteins, as well as a method for identifying 
individual binding sites within the transcriptome.  
 
Genome-wide identification of functional regulatory elements 
 The method currently used for identifying binding sites for a given RNA-binding 
protein relies on an experimentally determined consensus sequence. Two methods are 
frequently used to generate this consensus: identifying motifs in common among a 
population of sequences known to bind to the RNA-binding protein in question (using 
computational tools such as MEME or Cosmo), or measuring the affinities of a series of 
point mutations of a short, high-affinity binding sequence, followed by setting a threshold 
for significant mutations.  In the second approach, the consensus sequence is defined as 
the set of all mutations that weaken binding less than the chosen threshold.  Each of these 
approaches identifies the most common or highest affinity binding sites, but RNA-
binding proteins can also interact with weak or cryptic sites. For, example, the POS-1 
consensus failed to identify one of the two high-affinity sites within the glp-1 3′ UTR 
because of the presence of two changes relative to the consensus: a C in place of a purine, 
and a single nucleotide reduction in the length of the binding site. Based on the affinity 
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measurements described in Chaper II, the C substitution decreases affinity, while the 
reduction in length increases affinity by a comparable amount.  A simple consensus 
search will miss variations in binding sites such as this.  
 In at least one case, multiple weak binding sites for an RNA-binding protein in 
close proximity can elicit a similar regulatory response to a single strong binding site for 
that same protein.  FBF is a direct translational repressor of cki-2, which represses the C. 
elegans cyclin E homolog cye-1 and thus promotes mitosis in the distal end of the 
germline (Kalchhauser et al. 2011).  The cki-2 3′ UTR contains four FBF binding sites 
within 100 nucleotides.  Three of these sites have an affinity that is 10-fold weaker than 
that observed for FBF in complex with a functional regulatory element from the gld-1 3′ 
UTR, while the fourth has an equivalent affinity to that observed for the gld-1 binding 
site.  Mutation of only the highest affinity FBF site within the context of a reporter results 
in no detectable change relative to the wild-type sequence, while mutation of all four 
results in de-repression of the reporter in the distal end of the germline.  This implies that 
all four sites are required for translational repression, not just the highest affinity site.  
Thus, weak sites must also be taken into consideration when attempting to identify 
regulatory elements within the 3′ UTRs of translationally regulated mRNAs.  
 To identify both weak and strong sites, I have developed an algorithm based on 
the pairwise alignment algorithm that uses the quantitative in vitro measurements made 
for panels of point mutations for POS-1, GLD-1, and MEX-3.  By determining which 
nucleotides do not match the optimal nucleotide at each position and summing the 
measured ∆∆Gº for each mismatch, an estimate of the affinity for any arbitrary sequence 
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can be made.  This permits the identification of both weak and strong sites throughout the 
transcriptome. This method assumes that the effects of individual mutations are 
independent, and that the effect of multiple mutations is equivalent to the sum of the 
effects of the individual mutations. This assumption is valid for GLD-1 (Wright et al. 
2011). The affinities of 46 different seven-nucleotide sequences were measured.  These 
sequences were the most enriched motifs among a population of sequences recovered by 
RIP-CHIP from worm extract against GLD-1.  This population of motifs was sufficiently 
diverse to provide multiple opportunities to measure the effect of a point mutation within 
different sequence contexts. For nearly all point mutations measured, the relative effect of 
the mutation remained constant regardless of the sequence background it was found in.  
Mutations may not be independent for other RNA-binding proteins, but this is at least a 
reasonable hypothesis with regards to GLD-1.  
 Using this method, clusters of binding sites for POS-1, GLD-1, and MEX-3 can 
be identified throughout the entire C. elegans transcriptome and subsequently tested for 
regulatory activity via the generation of transgenic reporter strains. Clusters of binding 
sites may be more informative than individual binding sites alone, thus enabling the 
identification of regulatory regions of translationally regulated transcripts.  This will 
enable a greater understanding of the mechanism and function of POS-1 and other RNA-
binding protein mediated translational regulation in C. elegans, and this strategy could 
conceivably be extended to other species as well.  
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